<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-MDG-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Madagascar: Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Madagascar: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Madagascar</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="MG" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="MG" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Antananarivo</narrative>
   </name>
   <administrative code="MG" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-18.91433 47.53098</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">2594147</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">2484370</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">3342950</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">622156.1</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">622156.1</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="MDGPEF-TCA-CARDNO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">215914</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">422000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-CRS2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CRS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-DALBERG2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">185508</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">54406</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">43827</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">846720</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">825773</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-CARDNO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">21824</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-CDC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">187500</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-CRS2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">191477</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CRS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-DALBERG2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">705093</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">30669</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">49009</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">529200</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">769598</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-CDC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">62500</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-CRS2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">151383</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CRS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-DALBERG2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">918921</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">7600</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">78063</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">1037000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">1087484</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="MDGPEF-TCA-DALBERG2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001062">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">95423</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">59236</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001357">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-39290</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003849">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">69243</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006993">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">27213</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000800">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-10"></transaction-date>
   <value currency="USD" value-date="2019-12-10">4091</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-4091</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">4091</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000473">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-20"></transaction-date>
   <value currency="USD" value-date="2020-02-20">21213</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CARDNO (Cardno Emerging Markets USA)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Cardno Emerging Markets USA</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000926">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">316500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000748">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-03"></transaction-date>
   <value currency="USD" value-date="2019-12-03">105500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001736">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">187500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001205">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">62500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001513">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">40094</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CRS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-49167</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CRS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">49167</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CRS</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001035">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-16342</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001201">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">16061</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900006984">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">86364</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001262">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">3631</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000239">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">5799</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000240">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">89995</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001274">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-23"></transaction-date>
   <value currency="USD" value-date="2020-06-23">89995</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001847">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-09"></transaction-date>
   <value currency="USD" value-date="2020-07-09">89995</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002968">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-20"></transaction-date>
   <value currency="USD" value-date="2020-07-20">89995</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001550">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-18"></transaction-date>
   <value currency="USD" value-date="2020-08-18">12194</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004504">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">89995</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-95794</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">95794</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-17928</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">17928</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000224">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-21"></transaction-date>
   <value currency="USD" value-date="2021-01-21">43652</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000712">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-22"></transaction-date>
   <value currency="USD" value-date="2021-02-22">3206</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001639">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-13"></transaction-date>
   <value currency="USD" value-date="2021-04-13">84365</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004327">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-08"></transaction-date>
   <value currency="USD" value-date="2021-09-08">8385</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004307">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-20"></transaction-date>
   <value currency="USD" value-date="2021-09-20">15118</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003097">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-27"></transaction-date>
   <value currency="USD" value-date="2021-09-27">71865</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005077">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-06"></transaction-date>
   <value currency="USD" value-date="2021-12-06">246894</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006947">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-07"></transaction-date>
   <value currency="USD" value-date="2021-12-07">181230</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007118">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-09"></transaction-date>
   <value currency="USD" value-date="2021-12-09">7226</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000332">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-01"></transaction-date>
   <value currency="USD" value-date="2019-12-01">35298</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005505">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-11560</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005505">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">11560</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000078">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-14"></transaction-date>
   <value currency="USD" value-date="2021-01-14">11560</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-11"></transaction-date>
   <value currency="USD" value-date="2021-03-11">636</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">38776</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-2614</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">4098</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001193">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-29"></transaction-date>
   <value currency="USD" value-date="2020-03-29">14911</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-18063</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">18063</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">9563</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">8100</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">825</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">3225</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000927">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">793800</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">52920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000867">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">105840</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">277830</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-52920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">52920</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001377">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">46305</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002314">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-25"></transaction-date>
   <value currency="USD" value-date="2021-05-25">545359</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003306">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-13"></transaction-date>
   <value currency="USD" value-date="2021-07-13">399031</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000928">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">707805</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000231">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">117968</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">651630</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-117968</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">117968</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001826">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-27"></transaction-date>
   <value currency="USD" value-date="2021-04-27">108605</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002910">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-29"></transaction-date>
   <value currency="USD" value-date="2021-06-29">487214</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003404">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-20"></transaction-date>
   <value currency="USD" value-date="2021-07-20">383060</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-madagascar-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Madagascar 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-madagascar-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Madagascar 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-madagascar-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Madagascar 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-madagascar-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Madagascar 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-madagascar-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Madagascar 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-madagascar-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Madagascar 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-madagascar-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Madagascar 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-madagascar-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Madagascar 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-MDG" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN"># updated microplan available and implemented in 100% of districts. 
 # follow-up of the implementation of the outreach/fixed strategies during monthly IACC technical meeting 
&#xA0; # At least 80% of Monthly data analysis conducted at central level and feed back providedby emailto 22 regions for corrective actions.
&#xA0; # Second progress report including lessons learned on vaccination in urban strategy developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="# Technical support to the national REC coordination committee (updating REC tools and guideline, follow up, data analysis and monitoring)
 # Technical support to periodic monitoring meeting including identification of bottlenecks and suggestion of corrective actions to improve coverage and equity
 # Technical support for development and implementation of special strategies to reach hard to reach children, 
 
 # Support DPEV to adapt strategy / tools for vaccination in urban settings (micro plans, implementation and monitoring tools) for scaling up.
 # Support scale up of vaccination in urban settings in other cities,">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN"># 100% districts ont mis &#xE0; jour des microplans. Avec les orientations donnees, les POTs ont fourni un appui de qualite et assure le suivi avec les Districts pour mettre &#xE0; jour les microplans ACC en utilisant les donnees des analyses des donn&#xE9;es mensuelles de vaccination ou lors des supervisions formatives.
# Au niveau national, participation aux mensuelles validations donn&#xE9;es ; pour faire le suivi de la proportion des enfants vaccin&#xE9;s par strat&#xE9;gie. Elle est passee de 81% en Avril 2020 contre 77% en Avril 2021 pour SF et 17% en Avril 2020 contre 22% en Avril 2021
#Au niveau r&#xE9;gional, m&#xEA;me appui par les POTs plus un suivi du feed back aux districts. Les districts &#xE0; probl&#xE8;mes sont prioritaires pour la supervision. Appui &#xE0; l&apos;am&#xE9;lioration de la promptitude et compl&#xE9;tude. 
Contribution a la production du bulletin mensuel de retro-information diffus&#xE9; aux r&#xE9;gions et t&#xE9;l&#xE9;conf&#xE9;rence mensuelle avec les POTs pour le suivi de la mise en ?uvre des mesures correctrices. comparativement malgr&#xE9; la baisse de couverture vaccinale en DTCHepBHib 3 de 1% &#xE0; 14% en Avril 2021 compar&#xE9; &#xE0; la m&#xEA;me p&#xE9;riode de 2020, la couverture vaccinale connait une hausse progressive mais sans pour autant encore atteindre les couvertures de 2020 et l?objectif nationale (93%).
# Avec le consultant international charg&#xE9; de la mise &#xE0; l?&#xE9;chelle de l?approche urbaine, renforcement de capacit&#xE9;s des principaux acteurs des District et R&#xE9;gion, appui a la planification et la documentation &#xE0; travers des sessions virtuelles. Documentation de l?approche urbaine a &#xE9;t&#xE9; consolid&#xE9;e et partagee a un webinar r&#xE9;gional UNICEF OMS sur l?Immunization en milieu urbain y compris les le&#xE7;ons clefs dans les 4 villes. La prochaine etape sera la mise en oeuvre des microplans et la documentation des resultats sur les couvertures vaccinales</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="# Technical support to the national REC coordination committee (updating REC tools and guideline, follow up, data analysis and monitoring)
 # Technical support to periodic monitoring meeting including identification of bottlenecks and suggestion of corrective actions to improve coverage and equity
 # Technical support for development and implementation of special strategies to reach hard to reach children, 
 
 # Support DPEV to adapt strategy / tools for vaccination in urban settings (micro plans, implementation and monitoring tools) for scaling up.
 # Support scale up of vaccination in urban settings in other cities,">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN"># 100% districts ont mis &#xE0; jour des microplans. Avec les orientations donnees, les POTs ont fourni un appui de qualite et assure le suivi avec les Districts pour mettre &#xE0; jour les microplans ACC en utilisant les donnees des analyses des donn&#xE9;es mensuelles de vaccination ou lors des supervisions formatives.
# Au niveau national, participation aux mensuelles validations donn&#xE9;es ; pour faire le suivi de la proportion des enfants vaccin&#xE9;s par strat&#xE9;gie. Elle est passee de 81% en Avril 2020 contre 77% en Avril 2021 pour SF et 17% en Avril 2020 contre 22% en Avril 2021
#Au niveau r&#xE9;gional, m&#xEA;me appui par les POTs plus un suivi du feed back aux districts. Les districts &#xE0; probl&#xE8;mes sont prioritaires pour la supervision. Appui &#xE0; l&apos;am&#xE9;lioration de la promptitude et compl&#xE9;tude. 
Contribution a la production du bulletin mensuel de retro-information diffus&#xE9; aux r&#xE9;gions et t&#xE9;l&#xE9;conf&#xE9;rence mensuelle avec les POTs pour le suivi de la mise en ?uvre des mesures correctrices. comparativement malgr&#xE9; la baisse de couverture vaccinale en DTCHepBHib 3 de 1% &#xE0; 14% en Avril 2021 compar&#xE9; &#xE0; la m&#xEA;me p&#xE9;riode de 2020, la couverture vaccinale connait une hausse progressive mais sans pour autant encore atteindre les couvertures de 2020 et l?objectif nationale (93%).
# Avec le consultant international charg&#xE9; de la mise &#xE0; l?&#xE9;chelle de l?approche urbaine, renforcement de capacit&#xE9;s des principaux acteurs des District et R&#xE9;gion, appui a la planification et la documentation &#xE0; travers des sessions virtuelles. Documentation de l?approche urbaine a &#xE9;t&#xE9; consolid&#xE9;e et partagee a un webinar r&#xE9;gional UNICEF OMS sur l?Immunization en milieu urbain y compris les le&#xE7;ons clefs dans les 4 villes. La prochaine etape sera la mise en oeuvre des microplans et la documentation des resultats sur les couvertures vaccinales</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">#Two quaterly dilevery to districts completed
 # Monthly monitoring at central an distrcit level report available 
 # Mean of transport received, delivered / installed according to distribution plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="# Technical support to fully implement immunization supply chain process
 # Technical support to procure means of transport for region and districts
 #Technical support to strenthen cold chain capacity at operational level (regions, districts and CSB level 
 
 # Technical support for supply chain optimization system design
 
 # Provide suppot to CCEOP - Year 2 proposal development and submission">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN"># 2 livraisons trimestrielles des vaccins et autres intrants r&#xE9;alis&#xE9;es vers 114 districts par voie a&#xE9;rienne et terrestre suite a l?appui de qualite a l?&#xE9;laboration du plan de distribution des intrants dans le contexte particulier de tension sur les niveaux de stocks de routine et d?int&#xE9;gration de la vaccination contre la COVID19, la campagne riposte polio int&#xE9;gr&#xE9;e au renforcement de la routine et suppl&#xE9;mentation en Vitamine A dans 15 r&#xE9;gions et 85 districts sanitaires. 
# Monitorage mensuel des niveaux de stock au niveau central et district ; pour proposer un red&#xE9;ploiement entre districts/r&#xE9;gions et d?ajuster les besoins trimestriels dans le contexte de faible niveau de stocks lie au non-paiement de la contrepartie Etat du budget pour l?achat des vaccins. Appui &#xE0; la mise &#xE0; jour mensuelle des donnees dans l&apos;outil ViVa; &#xE0; la maitrise de l&apos;outil SMT par les partenaires et participe &#xE0; la r&#xE9;daction du rapport sur la gestion des vaccins et consommables. Appui au monitorage rapproche et quotidien des Vaccins COVAX afin de red&#xE9;ployer le vaccin l&#xE0; o&#xF9; la demande est forte pour maximiser leur utilisation avant la peremption.
# Pour le mat&#xE9;riel roulant, r&#xE9;ception et remise de motos pour 33 districts. Immatriculation en cours pour int&#xE9;gration parc automobile Etat. 
#Autres activites :
-Suivi CCEOP annee 2, conseils au pays pour maintien du choix du CCEOP annee 1, suivi validation par MSP et transmission a SD
-Inspection post installation (PII) CCEOP annee 1, finalisation sites &#xE0; visiter et suivi realisation avec le PMT Mise &#xE0; jour inventaires ECF, identification des gaps et proposition a Gavi pour ECF complementaires/COVAX
-Suivi projet construction d&#xE9;p&#xF4;ts de vaccins avec le chef de Projet ; analyse des dossiers du cabinet d&apos;architectures, validation APS et analyse APD</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="# Technical support to fully implement immunization supply chain process
 # Technical support to procure means of transport for region and districts
 #Technical support to strenthen cold chain capacity at operational level (regions, districts and CSB level 
 
 # Technical support for supply chain optimization system design
 
 # Provide suppot to CCEOP - Year 2 proposal development and submission">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN"># 2 livraisons trimestrielles des vaccins et autres intrants r&#xE9;alis&#xE9;es vers 114 districts par voie a&#xE9;rienne et terrestre suite a l?appui de qualite a l?&#xE9;laboration du plan de distribution des intrants dans le contexte particulier de tension sur les niveaux de stocks de routine et d?int&#xE9;gration de la vaccination contre la COVID19, la campagne riposte polio int&#xE9;gr&#xE9;e au renforcement de la routine et suppl&#xE9;mentation en Vitamine A dans 15 r&#xE9;gions et 85 districts sanitaires. 
# Monitorage mensuel des niveaux de stock au niveau central et district ; pour proposer un red&#xE9;ploiement entre districts/r&#xE9;gions et d?ajuster les besoins trimestriels dans le contexte de faible niveau de stocks lie au non-paiement de la contrepartie Etat du budget pour l?achat des vaccins. Appui &#xE0; la mise &#xE0; jour mensuelle des donnees dans l&apos;outil ViVa; &#xE0; la maitrise de l&apos;outil SMT par les partenaires et participe &#xE0; la r&#xE9;daction du rapport sur la gestion des vaccins et consommables. Appui au monitorage rapproche et quotidien des Vaccins COVAX afin de red&#xE9;ployer le vaccin l&#xE0; o&#xF9; la demande est forte pour maximiser leur utilisation avant la peremption.
# Pour le mat&#xE9;riel roulant, r&#xE9;ception et remise de motos pour 33 districts. Immatriculation en cours pour int&#xE9;gration parc automobile Etat. 
#Autres activites :
-Suivi CCEOP annee 2, conseils au pays pour maintien du choix du CCEOP annee 1, suivi validation par MSP et transmission a SD
-Inspection post installation (PII) CCEOP annee 1, finalisation sites &#xE0; visiter et suivi realisation avec le PMT Mise &#xE0; jour inventaires ECF, identification des gaps et proposition a Gavi pour ECF complementaires/COVAX
-Suivi projet construction d&#xE9;p&#xF4;ts de vaccins avec le chef de Projet ; analyse des dossiers du cabinet d&apos;architectures, validation APS et analyse APD</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - Financial Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN"># All amount due to procurment of vaccines paid by end of 2020
 # Situation repport on 2021 cofinancing status shared with MPH
 # In case of delay, reminder letter from UNICEF senior management to MPH
  
 # GAVI Grant managed by UNICEF financial report is submitted to the ICC 
 # HACT Training and Financial Capacity building done for UNICEF and MPH (national / regional / district) staffs
 
 # vaccines forecasting / procurement costing included in the Health Sector Development Plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="# Keep abreast of national budget commitment / expenditure and provide timely information to UNICEF Senior Management for advocacy to MPH for cofinancing and traditional vaccine procurement
 # Ensure Funds are managed in a transparent and accountable manner:
  @ Support the partner in reviewing requests prior to submisison to UNICEF to avoid discrepancies between planning, forecasting and funding allocated;
  @ Support the patner in reviewing expenditure supporting documents and reports
 # In collaboration with Program manager, support national /region/ district capacity building to ensure appropriate funding utilization and project execution">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">#Le suivi r&#xE9;gulier du paiement par l?Etat des obligations 2021 est fait avec le Ministere de la Sante, des Finances et Supply Division. Ce suivi corr&#xE9;l&#xE9; avec la situation des stocks de vaccins permet de construire le plaidoyer aupres du gouvernement pour la mobilisation des fonds sous forme de courrier de rappel ou de communication verbale par le Representant. C?est ainsi qu?en Fevrier 2021, le Pr&#xE9;sident avait annonce l?autorisation pour le paiement du reliquat de financement 2020 et le suivi est en cours pour l?inscription sur la Loi de finances rectificative de Juillet
# Le suivi r&#xE9;gulier de la gestion des fonds par les diff&#xE9;rentes directions du Minist&#xE8;re et les OSC de mise en ?uvre a &#xE9;t&#xE9; poursuivi. Grace a des r&#xE9;unions r&#xE9;guli&#xE8;res, j?ai fait le suivi en bilat&#xE9;rale et fournit un accompagnement continu afin de s?assurer que les activit&#xE9;s des partenaires soient mises en ?uvre financi&#xE8;rement suivant les r&#xE8;gles et proc&#xE9;dures. J?ai &#xE9;galement pu effectuer deux visites au niveau de deux partenaires aux fins de v&#xE9;rification et appui financiers, d?&#xE9;changes et de renforcement de capacit&#xE9;s dans le but de mitiger les risques.
Dans la m&#xEA;me approche, plus particuli&#xE8;rement, j?ai apport&#xE9; mon support &#xE0; l?accompagnement de la DPEV pour avoir une planification int&#xE9;gr&#xE9;e de leurs activit&#xE9;s et de ce fait &#xE9;viter les multiplications d?avances ponctuelles. Une implication syst&#xE9;matique du Service Administratif et Financier a &#xE9;t&#xE9; pr&#xE9;conis&#xE9;e afin d?assurer la constitution, la centralisation et la disponibilit&#xE9; des dossiers de requ&#xEA;te et de liquidation au niveau du Service Financier. 
# j?ai &#xE9;galement apport&#xE9; un support et un suivi des exercices d?audit de 4 partenaires, dans le cadre des activit&#xE9;s de mitigation de risques selon les r&#xE8;gles et proc&#xE9;dures HACT en vigueur.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="# Keep abreast of national budget commitment / expenditure and provide timely information to UNICEF Senior Management for advocacy to MPH for cofinancing and traditional vaccine procurement
 # Ensure Funds are managed in a transparent and accountable manner:
  @ Support the partner in reviewing requests prior to submisison to UNICEF to avoid discrepancies between planning, forecasting and funding allocated;
  @ Support the patner in reviewing expenditure supporting documents and reports
 # In collaboration with Program manager, support national /region/ district capacity building to ensure appropriate funding utilization and project execution">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">#Le suivi r&#xE9;gulier du paiement par l?Etat des obligations 2021 est fait avec le Ministere de la Sante, des Finances et Supply Division. Ce suivi corr&#xE9;l&#xE9; avec la situation des stocks de vaccins permet de construire le plaidoyer aupres du gouvernement pour la mobilisation des fonds sous forme de courrier de rappel ou de communication verbale par le Representant. C?est ainsi qu?en Fevrier 2021, le Pr&#xE9;sident avait annonce l?autorisation pour le paiement du reliquat de financement 2020 et le suivi est en cours pour l?inscription sur la Loi de finances rectificative de Juillet
# Le suivi r&#xE9;gulier de la gestion des fonds par les diff&#xE9;rentes directions du Minist&#xE8;re et les OSC de mise en ?uvre a &#xE9;t&#xE9; poursuivi. Grace a des r&#xE9;unions r&#xE9;guli&#xE8;res, j?ai fait le suivi en bilat&#xE9;rale et fournit un accompagnement continu afin de s?assurer que les activit&#xE9;s des partenaires soient mises en ?uvre financi&#xE8;rement suivant les r&#xE8;gles et proc&#xE9;dures. J?ai &#xE9;galement pu effectuer deux visites au niveau de deux partenaires aux fins de v&#xE9;rification et appui financiers, d?&#xE9;changes et de renforcement de capacit&#xE9;s dans le but de mitiger les risques.
Dans la m&#xEA;me approche, plus particuli&#xE8;rement, j?ai apport&#xE9; mon support &#xE0; l?accompagnement de la DPEV pour avoir une planification int&#xE9;gr&#xE9;e de leurs activit&#xE9;s et de ce fait &#xE9;viter les multiplications d?avances ponctuelles. Une implication syst&#xE9;matique du Service Administratif et Financier a &#xE9;t&#xE9; pr&#xE9;conis&#xE9;e afin d?assurer la constitution, la centralisation et la disponibilit&#xE9; des dossiers de requ&#xEA;te et de liquidation au niveau du Service Financier. 
# j?ai &#xE9;galement apport&#xE9; un support et un suivi des exercices d?audit de 4 partenaires, dans le cadre des activit&#xE9;s de mitigation de risques selon les r&#xE8;gles et proc&#xE9;dures HACT en vigueur.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">% of target sites (provinces/districts) that have updated CCE management documents like CCE inventory, Operational Deployment Plan (ODP) or Cold Chain Expansion and Rehabilitation Plan, CCE maintenance strategy etc.)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la disponibilite des vaccins de qualite jusqu&apos;au dernier kilometre: Activites: (i) Soutenir le processus complet d&apos;approvisionnement en intrants de vaccination pour la routine et les campagnes; (ii) Appuyer la mise en ?uvre de la 2e phase du CCEOP1 y compris le PII; (iii) Appuyer l&apos;elaboration du plan de mise en oeuvre du nouveau design de la Chaine d&apos;Approvisionnement integr&#xE9;e y compris l&apos;integrant des besoins dans le Full portefolio planning; (iv) Soutenir la realisation de la cartographie des chambres froides au niveau central et dans les regions ciblees">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">(i) Appui a l&apos;elaboration du forecast immunisation 2022 y compris la projection de 2023 a 2026 pour la routine et les campagnes. Suivi regulier avec SD des commandes des vaccins et consommables et appui a la mise a jour du plan de distribution tenant compte de la tension sur les stocks. les 114 districts ont recu deux approvisionnements pour la routine et deux pour la campagne de riposte Polio.
(ii)Suivi commande equipements du CCEOP annee 2. Ainsi 361 r&#xE9;frig&#xE9;rateurs solaires et 109 congelateurs &#xE9;lectriques livres au pays pour couvrir 13% des centres de sante et 95% des districts. 
Facilitation de la realisation de l&apos;inspection post installation (PII) des equipements du CCEOP annee 1 et accompagnement du prestataire selectionne par SD. Le rapport du PII est disponible.
(iii) Recrrutement du consultant en charge de l&apos;elaboration du plan de mise en eoeuvre du design est en cours. il sera operationnel en debut decembre 2021.
(v) Appui a l?acquisition des equipements (LogTag TRIX-8) et partage des outils pour la r&#xE9;alisation de la cartographie des chambres froides.Prochaine &#xE9;tape:formation, collecte de donnees, analyse et redaction de rapport de la cartographie des chambres froides du niveau central
Par ailleurs, les 33 motos acquises dans le cadre du RSS 2 ont &#xE9;te remises aux 33 districts b&#xE9;n&#xE9;ficiaires. Suivi avec le consultant du projet construction d&#xE9;p&#xF4;ts de vaccins.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Accounting/financial management system delivered and operational</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la gestion transparente et efficace des financements de la vaccination:
Activites: (i) Renforcer les capacit&#xE9;s au niveau national / r&#xE9;gional / district a la formulation des requetes de financement, a leur utilisation appropri&#xE9;e et leur justification; (ii) Faire le suivi des transfert des fonds et leur liquidation conformement aux procedures HACT">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">(i) Le suivi r&#xE9;gulier de la gestion des fonds par les diff&#xE9;rentes directions du Minist&#xE8;re et les OSC de mise en ?uvre a &#xE9;t&#xE9; poursuivi. Grace a des r&#xE9;unions r&#xE9;guli&#xE8;res, j?ai fait le suivi en bilat&#xE9;rale et fournit un accompagnement continu afin de s?assurer que les activit&#xE9;s des partenaires soient mises en ?uvre financi&#xE8;rement suivant les r&#xE8;gles et proc&#xE9;dures. Plus particuli&#xE8;rement, j?ai apport&#xE9; mon support &#xE0; l?accompagnement de la DPEV pour avoir une planification int&#xE9;gr&#xE9;e de leurs activit&#xE9;s, et specifiquement vu le contexte et les differents defis d&apos;urgence auxquels la DPEV doit faire face, afin d&apos;&#xE9;viter les multiplications d?avances ponctuelles, un appui pour l&apos;analyse de la meilleure approche a adopter en terme de type d&apos;execution a ete fournie. Une implication syst&#xE9;matique du Service Administratif et Financier continue a etre pr&#xE9;conis&#xE9;e afin d?assurer la constitution, la centralisation et la disponibilit&#xE9; des dossiers de requ&#xEA;te et de liquidation au niveau du Service Financier. 
(ii) Dans le cadre des activit&#xE9;s de mitigation de risques selon les r&#xE8;gles et proc&#xE9;dures HACT en vigueur, j?ai apport&#xE9; un support et un suivi des exercices de spot check de 5 partenaires, aisi que pour deux ateliers de renforcement de capacites pour 2 partenaires, celle de la DPEV etant en cours.
Par ailleurs, un suivi r&#xE9;gulier est fait pour le paiement par l?Etat des obligations 2021 avec le Ministere de la Sante, des Finances et Supply Division. Un courrier de rappel a ete envoye en aout 2021 aux Ministeres des Finances et de la Sante avec un point sur la situation des stocks comme argumentaire de l&apos;urgence de proceder au paiement. A l&apos;heure actuelle, une lettre d&apos;autorisation d&apos;engagement d&apos;un montant de 3,5 millions USD a ete formulee par le Ministre de la Sante Publique, signee par le Premier Ministre et sounmise a la signature du President de la Republique.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN"># Implement community awareness, active research and referral of lost children.
 
 # Implement the training sessions on community activity packages in all the priority districts and urban areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="# Support demand generation activities to recover lost and unvaccinated children in identified districts.
 
 # Technical support for the development of the training documents on the community activities package and for the implementation in priority districts 
 
 # Support development of communication plan for MCV2 introduction 
 
 # Technical support for the update of the national communication plan on EPI">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN"># J&apos;ai suivi et appuy&#xE9; le d&#xE9;veloppement, la mise en oeuvre et le rapportage dans les delais des activit&#xE9;s dans le cadre du partenariat avec COMARESS. Cela a permis a COMARESS de realiser toutes les activites prevues. Ainsi, entre septembre 2020 et mai 2021, 7622 enfants non vaccin&#xE9;s et perdus de vue, dont 5460 enfants &#xE2;g&#xE9;s de 0-11 mois, ont &#xE9;t&#xE9; rattrap&#xE9;s gr&#xE2;ce &#xE0; l&apos;appui de COMARESS dans les CSB &#xE0; probl&#xE8;mes des districts d&apos;intervention. Pendant la m&#xEA;me p&#xE9;riode, 6199 enfants perdus de vue, dont 4156 etaient &#xE2;g&#xE9;s de 0-11 mois, ainsi que 6046 enfants non vaccin&#xE9;s dont 4234 &#xE2;g&#xE9;s de 0-11 mois ont &#xE9;t&#xE9; r&#xE9;f&#xE9;r&#xE9;s apr&#xE8;s le d&#xE9;nombrement r&#xE9;alis&#xE9; par les OSC de COMARESS. De plus, les 196 s&#xE9;ances de dialogues communautaires ont permis de renforcer l&apos;engagement de 156 leaders religieux, de 491 chefs fokontany et 288 membres CCDS en faveur de la vaccination et de la sant&#xE9; maternelle, n&#xE9;onatale et infantile. Enfin, 22089 personnes ont &#xE9;t&#xE9; touch&#xE9;es par les messages dans le cadre des animations de sensibilisation communautaire, dont 5857 enfants, 8122 femmes et 6435 hommes.
# Compte tenu du contexte COVID-19 depuis 2020, certaines activit&#xE9;s du Minist&#xE8;re de la Sant&#xE9; Publique ont pris plus de temps dans la r&#xE9;alisation, comme la reactualisation du guide PAC qui est encore en cours de r&#xE9;vision et qui devrait &#xEA;tre disponible au troisi&#xE8;me trimestre 2021. Par ailleurs, la DPEV a priorise en S1 2021 la communication pour l&apos;introduction des vaccins contre COVID-19 et reporte en S2 le d&#xE9;veloppement de documents de communication sur le PEV de routine.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="# Support demand generation activities to recover lost and unvaccinated children in identified districts.
 
 # Technical support for the development of the training documents on the community activities package and for the implementation in priority districts 
 
 # Support development of communication plan for MCV2 introduction 
 
 # Technical support for the update of the national communication plan on EPI">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN"># J&apos;ai suivi et appuy&#xE9; le d&#xE9;veloppement, la mise en oeuvre et le rapportage dans les delais des activit&#xE9;s dans le cadre du partenariat avec COMARESS. Cela a permis a COMARESS de realiser toutes les activites prevues. Ainsi, entre septembre 2020 et mai 2021, 7622 enfants non vaccin&#xE9;s et perdus de vue, dont 5460 enfants &#xE2;g&#xE9;s de 0-11 mois, ont &#xE9;t&#xE9; rattrap&#xE9;s gr&#xE2;ce &#xE0; l&apos;appui de COMARESS dans les CSB &#xE0; probl&#xE8;mes des districts d&apos;intervention. Pendant la m&#xEA;me p&#xE9;riode, 6199 enfants perdus de vue, dont 4156 etaient &#xE2;g&#xE9;s de 0-11 mois, ainsi que 6046 enfants non vaccin&#xE9;s dont 4234 &#xE2;g&#xE9;s de 0-11 mois ont &#xE9;t&#xE9; r&#xE9;f&#xE9;r&#xE9;s apr&#xE8;s le d&#xE9;nombrement r&#xE9;alis&#xE9; par les OSC de COMARESS. De plus, les 196 s&#xE9;ances de dialogues communautaires ont permis de renforcer l&apos;engagement de 156 leaders religieux, de 491 chefs fokontany et 288 membres CCDS en faveur de la vaccination et de la sant&#xE9; maternelle, n&#xE9;onatale et infantile. Enfin, 22089 personnes ont &#xE9;t&#xE9; touch&#xE9;es par les messages dans le cadre des animations de sensibilisation communautaire, dont 5857 enfants, 8122 femmes et 6435 hommes.
# Compte tenu du contexte COVID-19 depuis 2020, certaines activit&#xE9;s du Minist&#xE8;re de la Sant&#xE9; Publique ont pris plus de temps dans la r&#xE9;alisation, comme la reactualisation du guide PAC qui est encore en cours de r&#xE9;vision et qui devrait &#xEA;tre disponible au troisi&#xE8;me trimestre 2021. Par ailleurs, la DPEV a priorise en S1 2021 la communication pour l&apos;introduction des vaccins contre COVID-19 et reporte en S2 le d&#xE9;veloppement de documents de communication sur le PEV de routine.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN"># Implement community awareness, active research and referral of lost children. # Implement the training sessions on community activity packages in all the priority districts and urban areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="# Support demand generation activities to recover lost and unvaccinated children in identified districts. # Technical support for the development of the training documents on the community activities package and for the implementation in priority districts # Support development of communication plan for MCV2 introduction # Technical support for the update of the national communication plan on EPI">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">(i) Pour le developpement des plans de participation communautaire utilisant l approche centree sur l&apos;utilisateur dans les 7 grandes villes, appui a la preparation des ateliers de formation des EMAD par l&apos;elaboration des termes de r&#xE9;f&#xE9;rence et mise a disposition des ressources financieres
(ii) Appui a la r&#xE9;alisation en continu de la veille informationnelle sur toutes les questions de sant&#xE9; y compris la vaccination. Resultats entre juillet et novembre 2021: la communaut&#xE9; est consciente de la faiblesse de couverture vaccinale de routine des enfants &#xE0; cause des nombreuses rumeurs et pr&#xE9;occupations sur la vaccination contre COVID-19 et craint un risque de flamb&#xE9;e des &#xE9;pid&#xE9;mies de rougeole et poliomy&#xE9;lite. Aussi, les communaut&#xE9;s se plaignent de la faible qualite de l&apos;accueile dans les centres de vaccination. Cette problematique est adressee dans le Plan de communication sur le PEV de routine 2022-2024 en cours de finalisation a travers le renforcement de capacit&#xE9;s en communication interpersonnelle des agents de sant&#xE9; et agents communautaires, ainsi que la sensibilisation communautaire sur la vaccination compl&#xE8;te des enfants.
(iii) Cartographie des ONG, OSC, autres associations engag&#xE9;es dans la promotion de la demande en vaccination et SMNI, appui au processus de recrutement du cabinet pour la signature du contrat avant fin novembre 2021
(iv) Evaluation et l&apos;identification des approches les plus pertinentes et efficaces pour s&apos;attaquer aux obstacles de genre &#xE0; la vaccination, les termes de reference pour le recrutement du prestataire sont finalises.
(v) Revue externe du PEV, participation aux reunions preparatoires, &#xE0; la revue documentaire et appui a la collecte des donnees sur le terrain en impliquant les collegues au niveau decentralise.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Communication and social mobilization strategy developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Renforcer l?utilisation de service de soins &#xE0; travers la stimulation de la demande. Activites: (i) Appuyer la planification et la conception de services et des interventions de participation communautaire de qualite utilisant l&apos;approche centree sur l&apos;utilisateur (assistance technique dans le renforcement de capacites, la realisation de la recherche et le developpement du plan) dans chacune des 8 grandes villes; (ii) Appuyer la mise en place d&apos;un systeme d&apos;ecoute sociale continu pour la gestion des rumeurs, desinformations sur la vaccination y compris COVID-19 dans 7 grandes villes; (iii) Realiser une cartographie des ONG, OSC, autres associations engagees dans la promotion de la demande en vaccination et SMNI; (iv) Appuyer l&apos;evaluation et l&apos;identification des approches les plus pertinentes et efficaces pour s&apos;attaquer aux obstacles de genre a la vaccination (v) Appuyer la revue externe du PEV sur la composante communication">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">(i) Pour le developpement des plans de participation communautaire utilisant l approche centree sur l&apos;utilisateur dans les 7 grandes villes, appui a la preparation des ateliers de formation des EMAD par l&apos;elaboration des termes de r&#xE9;f&#xE9;rence et mise a disposition des ressources financieres
(ii) Appui a la r&#xE9;alisation en continu de la veille informationnelle sur toutes les questions de sant&#xE9; y compris la vaccination. Resultats entre juillet et novembre 2021: la communaut&#xE9; est consciente de la faiblesse de couverture vaccinale de routine des enfants &#xE0; cause des nombreuses rumeurs et pr&#xE9;occupations sur la vaccination contre COVID-19 et craint un risque de flamb&#xE9;e des &#xE9;pid&#xE9;mies de rougeole et poliomy&#xE9;lite. Aussi, les communaut&#xE9;s se plaignent de la faible qualite de l&apos;accueile dans les centres de vaccination. Cette problematique est adressee dans le Plan de communication sur le PEV de routine 2022-2024 en cours de finalisation a travers le renforcement de capacit&#xE9;s en communication interpersonnelle des agents de sant&#xE9; et agents communautaires, ainsi que la sensibilisation communautaire sur la vaccination compl&#xE8;te des enfants.
(iii) Cartographie des ONG, OSC, autres associations engag&#xE9;es dans la promotion de la demande en vaccination et SMNI, appui au processus de recrutement du cabinet pour la signature du contrat avant fin novembre 2021
(iv) Evaluation et l&apos;identification des approches les plus pertinentes et efficaces pour s&apos;attaquer aux obstacles de genre &#xE0; la vaccination, les termes de reference pour le recrutement du prestataire sont finalises.
(v) Revue externe du PEV, participation aux reunions preparatoires, &#xE0; la revue documentaire et appui a la collecte des donnees sur le terrain en impliquant les collegues au niveau decentralise.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 40% of EVM recommendations are implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support for the implementation of internal and external evaluations of vaccine management, including EVM. Support the implementation of recommendations from evaluations of effective vaccine management.
Support District Level Capacity Building in Vaccine Management">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">1- Evaluation du plan d&apos;am&#xE9;lioration GEV 2014 (50 activit&#xE9;s planifi&#xE9;es : 22 sont compl&#xE8;tements r&#xE9;alis&#xE9;es 44%, 16 en cours de r&#xE9;alisation 32%, 12 non r&#xE9;alis&#xE9;es 24%)
2- Evaluation GEV 2020 avec l&apos;appui des experts de l&apos;OMS/AFRO et du consultant international : le rapport est disponible
3- Elaboration du plan d&apos;am&#xE9;lioration de la GEV 2021-2025 : r&#xE9;alis&#xE9; avec l&apos;appui de toutes les parties prenantes. Le plan est disponible, en attente de diffusion.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support for the implementation of internal and external evaluations of vaccine management, including EVM. Support the implementation of recommendations from evaluations of effective vaccine management.
Support District Level Capacity Building in Vaccine Management">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">1- Evaluation du plan d&apos;am&#xE9;lioration GEV 2014 (50 activit&#xE9;s planifi&#xE9;es : 22 sont compl&#xE8;tements r&#xE9;alis&#xE9;es 44%, 16 en cours de r&#xE9;alisation 32%, 12 non r&#xE9;alis&#xE9;es 24%)
2- Evaluation GEV 2020 avec l&apos;appui des experts de l&apos;OMS/AFRO et du consultant international : le rapport est disponible
3- Elaboration du plan d&apos;am&#xE9;lioration de la GEV 2021-2025 : r&#xE9;alis&#xE9; avec l&apos;appui de toutes les parties prenantes. Le plan est disponible, en attente de diffusion.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Dalberg Global Development Advisors</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The various comments received on the manual of procedures will be integrated to finalize the document. The MP will support the EPI team in the implementation of new procedures. He/She will propose amendments of the EPI?s manual of procedures to improve the program?s effectiveness.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the organizational improvement of the EPI by developing a manual of procedures. The manual of procedures will codify strategic objectives and program management procedures and will play a pivotal role in ensuring the efficiency and effectiveness of the teams.">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">A ce stade, le document des normes et proc&#xE9;dures du PEV Madagascar int&#xE8;gre les diff&#xE9;rents commentaires du PEV et est en cours de finalisation. Par ailleurs, les cadres b&#xE9;n&#xE9;ficient de coaching en r&#xE9;solution de probl&#xE8;mes d&apos;ordre manag&#xE9;rial ou organisationnel pour son appropriation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Dalberg Global Development Advisors : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; Strategic indicators for monitoring/improving EPI performance have been identified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">1A et 1B : les parties prenantes ont travaill&#xE9; sur l&apos;identification des indicateurs strat&#xE9;giques et op&#xE9;rationnels lors de l&apos;atelier op&#xE9;rationnel qui s&apos;est d&#xE9;roul&#xE9; &#xE0; Kindia le 2 et 3 juin 2021 sur base d&apos;une liste de 41 indicateurs provenant du cadre de performance du PEV. Pour chaque niveau de la pyramide sanitaire, les indicateurs les plus pertinents ont &#xE9;t&#xE9; identifi&#xE9;s.
En synth&#xE8;se, 16 indicateurs peuvent &#xEA;tre consid&#xE9;r&#xE9;s comme prioritaires dans la mesure o&#xF9; ils sont pertinents soit pour les acteurs cl&#xE9;s de l&apos;&#xE9;cosyst&#xE8;me, soit pour le Minist&#xE8;re. =&gt; Completed
1C: Ces indicateurs seront valid&#xE9;s lors de la reunion du comit&#xE9; technique du SNIS dans le courant du mois de Juillet. Cette r&#xE9;union devait se tenir le 24 juin mais les membres du comit&#xE9; SNIS &#xE9;tant en mission sur le terrain jusqu&apos;&#xE0; la fin du mois de juin, la r&#xE9;union a donc d&#xFB; &#xEA;tre report&#xE9;e &#xE0; une date ult&#xE9;rieure . =&gt; Minor delays
1D: L&apos;essentiel des informations n&#xE9;cessaires &#xE0; l&apos;&#xE9;tablissement du cadre de gouvernance cible ont &#xE9;t&#xE9; collect&#xE9;es. Il a aussi permis de faire une cartographie des instances de gouvernance existantes &#xE0; tous les niveaux de la pyramide sanitaire. Le cadre de gouvernance sera valid&#xE9; lors de la r&#xE9;union du comit&#xE9; technique du SNIS dans le courant du mois de juillet. Cette r&#xE9;union devait se tenir le 24 juin mais les membres du comit&#xE9; SNIS &#xE9;tant en mission sur le terrain jusqu&apos;&#xE0; la fin du mois de juin, la r&#xE9;union a donc d&#xFB; &#xEA;tre report&#xE9;e &#xE0; une date ult&#xE9;rieure =&gt; Minor delays
1E: Sur la base des informations obtenues lors des diff&#xE9;rents &#xE9;changes avec les parties prenantes au niveau central mais &#xE9;galement lors de l&apos;atelier op&#xE9;rationnel, l&apos;&#xE9;quipe de Dalberg a d&#xE9;fini le dispositif de suivi des indicateurs, que ce soit au niveau du pilotage qu&apos;au niveau de l&apos;&#xE9;volution de l&apos;&#xE9;tendue des indicateurs.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">completed&apos; en H1 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; Operational indicators are identified and selected in agreement with the EPI manager</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">1B : L&apos;&#xE9;quipe de Dalberg a recolt&#xE9; la liste des indicateurs aupr&#xE8;s des parties prenantes. Les indicateurs obtenus sont d&#xE9;j&#xE0; class&#xE9;s dans les 5 onglets du tableau de bord. La classification &quot;op&#xE9;rationnel et strat&#xE9;gique&quot; sera faite apr&#xE8;s la priorisation des indicateurs =&gt; On track</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; Strategic and operational indicators are validated by the steering committee</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">1C: L&apos;&#xE9;quipe de Dalberg travaille actuellement sur la priorisation des indicateurs avec la DPEV. Cette liste sera valid&#xE9;e lors de la r&#xE9;union du comit&#xE9; PAD le 7 Juillet 2021*=&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le document &quot;cadre de gouvernance&quot;, ainsi que le m&#xE9;canisme de la gestion des indicateurs ont &#xE9;t&#xE9; pr&#xE9;sent&#xE9;s au niveau du comit&#xE9; PAD, puis valid&#xE9; par celui-ci lors de la r&#xE9;union du 21 juillet 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; The governance framework of the dashboard from the subnational level to the central level is developed and validated by the steering committee</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">1D : Le cadre de gouvernance du tableau de bord depuis le niveau d&#xE9;centralis&#xE9; jusqu&apos;au niveau central est finalis&#xE9; et sera valid&#xE9; lors de la r&#xE9;union du comit&#xE9; PAD du 7 Juillet 2021* =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le document &quot;cadre de gouvernance&quot;, ainsi que le m&#xE9;canisme de la gestion des indicateurs ont &#xE9;t&#xE9; pr&#xE9;sent&#xE9;s au niveau du comit&#xE9; PAD, puis valid&#xE9; par celui-ci lors de la r&#xE9;union du 21 juillet 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; The system for managing and monitoring the indicators in the dashboard is drawn up, validated by the steering committee and shared at all levels.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">1E: Le syst&#xE8;me de gestion des indicateurs est d&#xE9;taill&#xE9; dans le document sur le cadre de performance. Le document sera valid&#xE9; lors de la r&#xE9;union du comit&#xE9; PAD le 7 juillet 2021*. L&apos;envoi de ce dernier aupres des districts sera effectu&#xE9; apr&#xE8;s validation =&gt; Minor delays
1F: Le plan de d&#xE9;ployement du tableau de bord est &#xE9;tabli =&gt; Completed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A plan for rolling out the dashboard at all levels is defined</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">1F: Le plan de d&#xE9;ploiement du tableau de bord est &#xE9;tabli =&gt; Completed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; Required / existing data sources are collected on a regular basis.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data collection:
- Assess the required data sources (during a workshop with the end users to assess their needs)
- Assess the existing data sources and identify missing data sources (develop data collection tools)
- Create data collection &amp; integration processes on a regular basis">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">2A: Les outils de collecte de donn&#xE9;es existants sont disponibles et sont utilis&#xE9;s par les parties prenantes =&gt; Completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0; Data collection tools for required non-existing data sources have been developed and demonstrated their capacity to collect required data sets</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data collection:
- Assess the required data sources (during a workshop with the end users to assess their needs)
- Assess the existing data sources and identify missing data sources (develop data collection tools)
- Create data collection &amp; integration processes on a regular basis">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">2B: L&apos;&#xE9;quipe est en cours d&apos;&#xE9;valuation des besoins et specificit&#xE9;s des outils techniques necessaires &#xE0; la collecte des donn&#xE9;es des indicateurs prioris&#xE9;s avec la DPEV mais ne figurant pas encore dans les outils de collectes existants =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data collection: - Assess the required data sources (during a workshop with the end users to assess their needs) - Assess the existing data sources and identify missing data sources (develop data collection tools) - Create data collection &amp; integration processes on a regular basis">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">es nouveaux outils de collecte de donn&#xE9;es au niveau district, r&#xE9;gional et central ont &#xE9;t&#xE9; d&#xE9;velopp&#xE9;s et ont fait l&apos;objet d&apos;une formation au niveau de 3 districts et 3 r&#xE9;gions (Antananarivo Ville-Analamanga, Maevatanana-Betsiboka et MahajangaII-Boeny).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Version V0 or MVP (Minimum Viable Product) is a generic/skeleton version of the dashboard. The infrastructure and the main features are built and available for first users. The dashboard already displays some data results but not all of them.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Dashboard tool development:
- Develop the infrastructure
- Build the backend (data computation and processing)
- Design the frontend/dashboard
- Develop the frontend&apos;s features">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">3A: 
L&apos;&#xE9;quipe technique est actuellement en phase de d&#xE9;veloppement de la version V0 du tableau de bord, avec les informations disponibles du DHIS2 du Minist&#xE8;re de la sant&#xE9; (donn&#xE9;es g&#xE9;n&#xE9;rales). La V0 du tableau de bord contiendra dans un premier temps uniquement les indicateurs avec des informations existantes.
Cependant, cette version ne sera disponible aux premiers utilisateurs (points focaux) que dans le courant de Q3 2021. Ce retard est d&#xFB; aux raisons suivantes : 
- organisation tardive des ateliers d&#xFB; au contexte sanitaire, notamment l&apos;indisponibilit&#xE9; des parties prenantes qui sont frequemment sur le terrain. En effet, l&apos;atelier strat&#xE9;gique a &#xE9;t&#xE9; organis&#xE9; le 09 Juin 2021 et l&apos;atelier op&#xE9;rationnel les 10 et 11 Juin 2021.
- souci d&apos;avoir des indicateurs identifi&#xE9;s et un outil pertinent pour les utilisateurs, la conduite de ces ateliers &#xE9;taient d&#xE9;terminante afin de d&#xE9;finir les indicateurs et les specificit&#xE9;s fonctionnelles de l&apos;outil =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Dashboard tool development: - Develop the infrastructure - Build the backend (data computation and processing) - Design the frontend/dashboard - Develop the frontend&apos;s features">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">La version V0 a &#xE9;t&#xE9; d&#xE9;velopp&#xE9;e, puis d&#xE9;ploy&#xE9;e dans l&apos;instance DHIS2 formation du minist&#xE8;re de la sant&#xE9; publique en octobre 2021. Les utilisateurs ont d&#xE9;j&#xE0; la possibilit&#xE9; d&apos;acc&#xE9;der au tableau de bord dans l&apos;instance de formation.
Une d&#xE9;monstration du tableau de bord a &#xE9;t&#xE9; faite lors des formations de terrain en novembre 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; The mapping of governance and coordination bodies at the central and decentralized levels is completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">4A: Toutes les instances de gouvernance ont &#xE9;t&#xE9; identifi&#xE9;es et r&#xE9;pertori&#xE9;es, du niveau central jusqu&apos;au niveau d&#xE9;centralis&#xE9;. =&gt; Completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; An analysis of each governance body is carried out and a road map for transformation is developed at central, regional and district levels</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">4B: L&apos;analyse des parties prenantes et diff&#xE9;rents acteurs, ainsi que le syst&#xE8;me de gouvernance a &#xE9;t&#xE9; &#xE9;tablie. Cette analyse a permis de d&#xE9;terminer les pistes d&apos;am&#xE9;liorations du cadre de gouvernance du tableau de bord. =&gt; Completed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; A support (Gap-filling) to the planning, management and implementation of financial and programmatic activities is provided in the first six months in the selected districts to accelerate delivery and to have a better understanding of the different processes</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve management practices and planning process at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">6A: L&apos;assistance aux acteurs dans leur activit&#xE9;s de planification est un processus continu. En ce sens, l&apos;&#xE9;quipe de Dalberg assiste les &#xE9;quipes du PEV dans l&apos;organisation de leurs instances de coordination. Des discussions fr&#xE9;quentes ont lieu avec les &#xE9;quipes du PEV sur le support n&#xE9;cessaire et ad&#xE9;quat des &#xE9;quipes de Dalberg dans les activit&#xE9;s quotidiennes du PEV =&gt; On track</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;  Dedicated training to selected end users (champions) + knowledge transfer</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support and maintenance">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">7A: Dans un processus continu, les &#xE9;quipes Dalberg transf&#xE8;rent leurs connaissances techniques et fonctionnelles aupr&#xE8;s des parties prenantes afin d&apos;assurer une familiarisation des technologies aupr&#xE8;s de ces derni&#xE8;res. La formation &#xE0; proprement parler se d&#xE9;roulera une fois que le tableau de bord sera d&#xE9;ploy&#xE9; aupr&#xE8;s des champions identifi&#xE9;s =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;  Maintenance and support</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support and maintenance">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">7B: Le support et la maintenance du tableau de bord &#xE0; proprement parler d&#xE9;butera suite &#xE0; la mise &#xE0; disposition de la V0. N&#xE9;anmoins, les &#xE9;quipes de Dalberg restent &#xE0; la disposition des parties prenantes pour toutes questions concernant les sp&#xE9;cificit&#xE9;s fonctionnelles et techniques du projet =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Knowledge transfer</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support and maintenance">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; en continu. Des formations sur la cartographie et l&apos;utilisation de DHIS2 ont &#xE9;t&#xE9; men&#xE9;es pour les staffs de la division &quot;suivi &#xE9;valuation&quot; de la DPEV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; The mapping of the planning process is developed and analyzed. Strengths and weaknesses are identified, and recommendations are developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve management practices and planning process at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Des interviews au niveau de la DEPSI, DPEV et aux niveaux d&#xE9;centralis&#xE9;s ont permis d&apos;&#xE9;tablir un document sur le processus de planification. Ce document sera ensuite utilis&#xE9; pendant un atelier avec la division suivi &#xE9;valuation et data du service technique de vaccination (STV) de la DPEV.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; An evaluation framework and a timeline for reviewing EPI performances at the central level and in the selected districts are developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Des s&#xE9;ances de travail avec l&apos;&#xE9;quipe de la DPEV et celle de la DGMP ont &#xE9;t&#xE9; men&#xE9;es au mois de juillet. Compte tenu de leurs disponibilit&#xE9;s, la pr&#xE9;sentation du document aupr&#xE8;s des staffs de la DPEV ne sera possible que vers le d&#xE9;but de l&apos;ann&#xE9;e 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Coaching sessions on the use of the dashboard to monitor key indicators and make appropriate decisions are conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Etant donn&#xE9; que la formation au niveau des districts sera effective au mois de d&#xE9;cembre, la supervision formative et le coaching sur l&apos;utilisation du tableau de bord seront possibles &#xE0; partir du d&#xE9;but de l&apos;ann&#xE9;e 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Support to the EPI in the preparation and presentation of the various programmatic and financial reports will be provided</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Etant donn&#xE9; que la formation au niveau des districts sera effective au mois de d&#xE9;cembre, la supervision formative et le coaching sur l&apos;utilisation du tableau de bord seront possibles &#xE0; partir du d&#xE9;but de l&apos;ann&#xE9;e 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; Dedicated training to selected end users (champions) + knowledge transfer</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support and maintenance">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">La formation sur l&apos;utilisation du tableau de bord PEV, l&apos;immunization analysis et le data quality tool a &#xE9;t&#xE9; men&#xE9;e au niveau des 3 districts phase1 (Antananarivo ville, MahajangaII et Maevatanana). Le transfer knowledge est un processus continu qui se d&#xE9;roule sur l&apos;ensemble des activit&#xE9;s men&#xE9;es.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Version 1 is the final version of the dashboard. The infrastructure and all the required features are built and available for all the users. The dashboard displays all the data results</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Dashboard tool development:
- Develop the infrastructure
- Build the backend (data computation and processing)
- Design the frontend/dashboard
- Develop the frontend&apos;s features">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">La version V0 est d&#xE9;ploy&#xE9;e dans la plateforme DHIS2, instance de formation du minist&#xE8;re. La formation sur l&apos;utilisation de cette version a &#xE9;t&#xE9; men&#xE9;e en octobre pour trois districts : Tana Ville, MahajangaII et Maevatanana. La collecte des feedbacks est en cours pour ces trois districts. La collecte des feedbacks de la version 0 est en cours et permettra de d&#xE9;finir la feuille de route de la V1 que l&apos;&#xE9;quipe Dalberg pr&#xE9;voit de finaliser pour la fin de l&apos;ann&#xE9;e 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; An improvement plan of the planning process including all partners, the Ministry of Health, the EPI and the departments in charge of planning is developed and shared</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve management practices and planning process at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le document &#xE9;tabli avec l&apos;&#xE9;quipe de STV, d&#xE9;taillant toutes les forces et faiblesses sur le processus de planification actuel, sera utilis&#xE9; dans un atelier de 4 jours pr&#xE9;vu au mois de D&#xE9;cembre 2021 avec toutes les parties prenantes du projet afin de permettre l&apos;&#xE9;laboration d&apos;un plan d&apos;am&#xE9;lioration du processus de planification.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; Maintenance and support</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support and maintenance">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le support et la maintenance du tableau de bord &#xE0; proprement parler d&#xE9;butera lors de l&apos;utilisation de la V0 par les utilisateurs . N&#xE9;anmoins, les &#xE9;quipes de Dalberg restent &#xE0; la disposition des parties prenantes pour toutes questions concernant les sp&#xE9;cificit&#xE9;s fonctionnelles et techniques du projet.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Maintenance and support</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support and maintenance">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le support et la maintenance du tableau de bord &#xE0; proprement parler d&#xE9;butera lors de l&apos;utilisation de la V0 par les utilisateurs . N&#xE9;anmoins, les &#xE9;quipes de Dalberg restent &#xE0; la disposition des parties prenantes pour toutes questions concernant les sp&#xE9;cificit&#xE9;s fonctionnelles et techniques du projet.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The selected districts are trained on the governance and accountability framework under the leadership of the EPI</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le th&#xE8;me sur la gouvernance et le cadre de redevabilit&#xE9; a &#xE9;t&#xE9; abord&#xE9; pendant la formation. Trois r&#xE9;gions ont b&#xE9;n&#xE9;fici&#xE9; de cette formation. A travers la formation au niveau d&#xE9;centralis&#xE9;, 14 staffs issus des r&#xE9;gions et districts et 45 agents de sant&#xE9; au niveau des formations sanitaires ont &#xE9;t&#xE9; form&#xE9;s</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; All required data sources are collected on a regular basis</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data collection:
- Assess the required data sources (during a workshop with the end users to assess their needs)
- Assess the existing data sources and identify missing data sources (develop data collection tools)
- Create data collection &amp; integration processes on a regular basis">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Les donn&#xE9;es ont &#xE9;t&#xE9; collect&#xE9;es r&#xE9;guli&#xE8;rement &#xE0; travers le rapport mensuel des activit&#xE9;s au niveau des formations sanitaires. Des outils suppl&#xE9;mentaires au niveau des districts et r&#xE9;gions ont &#xE9;t&#xE9; con&#xE7;us ou bien am&#xE9;lior&#xE9;s pendant ce semestre. Ces outils ont ensuite &#xE9;t&#xE9; int&#xE9;gr&#xE9;s dans la plateforme DHIS2 du minist&#xE8;re. Puis, ces outils ont fait l&apos;objet de formation &#xE0; tous les niveaux pour les trois districts : Tana Ville, Maevatanana et Mahajanga II. Le suivi de l&apos;adoption des nouveaux outils sera effectu&#xE9; &#xE0; partir du mois de novembre 2021 pour les trois districts form&#xE9;s en octobre et janvier 2022 pour les 2 districts restants.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Decision-making committees are revitalized or created as necessary</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Suite &#xE0; la recommandation lors de l&apos;atelier strat&#xE9;gique du projet, le projet a &#xE9;t&#xE9; int&#xE9;gr&#xE9; au niveau du comit&#xE9; PAD (Plan d&apos;am&#xE9;lioration des Donn&#xE9;es). Ce comit&#xE9;, qui n&apos;a eu aucune r&#xE9;union pendant les p&#xE9;riodes de confinement, a eu sa premi&#xE8;re r&#xE9;union de l&apos;ann&#xE9;e en juillet 2021 gr&#xE2;ce &#xE0; l&apos;appui du projet. Cette r&#xE9;union a &#xE9;t&#xE9; une opportunit&#xE9; pour le projet de valider le document sur le cadre de gouvernance et le m&#xE9;canisme d&apos;identification des indicateurs pour le tableau de bord.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Tools for quality control of administrative, programmatic and financial data are designed, implemented and rolled out through a collaborative approach, with the involvement of health staff and communities, with the opportunity.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve data collection and use at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Un outil sur la v&#xE9;rification de la qualit&#xE9; des donn&#xE9;es existe d&#xE9;j&#xE0; au niveau de la DPEV. Cet outil permet une v&#xE9;rification approfondie de la qualit&#xE9; des donn&#xE9;es &#xE0; tous les niveaux. La probl&#xE9;matique pour Madagascar est la conduite effective et syst&#xE9;matique de l&apos;analyse qualit&#xE9; des donn&#xE9;es &#xE0; tous les niveaux. Ainsi, une formation portant sur la gestion de la qualit&#xE9; des donn&#xE9;es a &#xE9;t&#xE9; men&#xE9;e au niveau des 3 districts (Tana ville, Mahajanga II et Maevatanana).
En plus de la v&#xE9;rification physique des rapports &#xE0; tous les niveaux, une formation a &#xE9;t&#xE9; men&#xE9;e pour les acteurs &#xE0; tous les niveaux sur le &quot;Data Quality Tool&quot;, qui est un outil d&#xE9;velopp&#xE9; par HISP avec l&apos;appui de Gavi et OMS.
Et finalement, Dalberg a appuy&#xE9; l&apos;int&#xE9;gration des r&#xE8;gles de validation des donn&#xE9;es lors de la saisie des donn&#xE9;es au niveau district.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; Tools for the preparation and management of decision-making bodies are developed at all levels.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Reorganize and support decision-making committees at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Un outil sur la v&#xE9;rification de la qualit&#xE9; des donn&#xE9;es existe d&#xE9;j&#xE0; au niveau de la DPEV. Cet outil permet une v&#xE9;rification approfondie de la qualit&#xE9; des donn&#xE9;es &#xE0; tous les niveaux. La probl&#xE9;matique pour Madagascar est la conduite effective et syst&#xE9;matique de l&apos;analyse qualit&#xE9; des donn&#xE9;es &#xE0; tous les niveaux. Ainsi, une formation portant sur la gestion de la qualit&#xE9; des donn&#xE9;es a &#xE9;t&#xE9; men&#xE9;e au niveau des 3 districts (Tana ville, Mahajanga II et Maevatanana).
En plus de la v&#xE9;rification physique des rapports &#xE0; tous les niveaux, une formation a &#xE9;t&#xE9; men&#xE9;e pour les acteurs &#xE0; tous les niveaux sur le &quot;Data Quality Tool&quot;, qui est un outil d&#xE9;velopp&#xE9; par HISP avec l&apos;appui de Gavi et OMS.
Et finalement, Dalberg a appuy&#xE9; l&apos;int&#xE9;gration des r&#xE8;gles de validation des donn&#xE9;es lors de la saisie des donn&#xE9;es au niveau district.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7; Systematic data collection and support for the revitalization of the data validation committees is ensured through a support plan with communities and districts, in close collaboration with technical partners (particularly WHO)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve data collection and use at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Deux r&#xE9;unions d&apos;analyse et de validation des donn&#xE9;es ont eu lieu au niveau central.
En ao&#xFB;t 2021, une r&#xE9;union portant sur l&apos;utilisation et la compl&#xE9;mentarit&#xE9; des tableaux de bord existants dans le DHIS2 avec le tableau de bord d&#xE9;velopp&#xE9; par l&apos;&#xE9;quipe de Dalberg a eu lieu. Cette r&#xE9;union a permis de conclure la n&#xE9;cessit&#xE9; de proposer une formation &apos;en package&apos; pour le niveau central et d&#xE9;centralis&#xE9;. La formation va surtout porter sur l&apos;utilisation des donn&#xE9;es dans les revues des donn&#xE9;es, les supervisions, l&apos;analyse de la qualit&#xE9; des donn&#xE9;es et la planification.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Improve data collection and use at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Une collaboration continue est men&#xE9;e entre l&apos;&#xE9;quipe Pays Dalberg et la DEPSI afin de permettre l&apos;int&#xE9;gration de l&apos;ensemble des donn&#xE9;es dans le DHIS2.
Au niveau central: la validation des donn&#xE9;es est men&#xE9;e mensuellement par le comit&#xE9; PAD. L&apos;&#xE9;quipe Pays Dalberg est int&#xE9;gr&#xE9;e dans les activit&#xE9;s du comit&#xE9; PAD et va participer &#xE0; l&apos;ensemble des r&#xE9;unions de validation des donn&#xE9;es afin d&apos;apporter un soutien strat&#xE9;gique et nec&#xE9;ssaire 
Au niveau d&#xE9;centralis&#xE9; : la validation des donn&#xE9;es a &#xE9;t&#xE9; discut&#xE9;e pendant l&apos;atelier op&#xE9;rationnel. Cette derni&#xE8;re n&apos;est actuellement pas effectu&#xE9;e de mani&#xE8;re r&#xE9;guli&#xE8;re au niveau d&#xE9;centralis&#xE9;, les &#xE9;quipes de Dalberg ont propos&#xE9; leur support pour le d&#xE9;ploiement de cette validation. L&apos;&#xE9;quipe Pays Dalberg va collaborer avec l&apos;OMS pour proposer des strat&#xE9;gies de support afin de soutenir les niveaux d&#xE9;centralis&#xE9;s dans leur collecte de donn&#xE9;es de mani&#xE8;re efficace et p&#xE9;renne lors et apr&#xE8;s le d&#xE9;ploiement du projet =&gt; Minor delays</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">&#xB7;&#xA0;&#xA0; An accountability framework is established in collaboration with the partners and validated by the steering committee.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establish dashboard governance mechanisms at the central level and in selected regions and districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Une liste des r&#xF4;les et responsabilit&#xE9;s des acteurs &#xE0; tous les niveaux est disponible dans le document des normes et proc&#xE9;dures SIS du minist&#xE8;re de sant&#xE9;. Cette liste a &#xE9;t&#xE9; reprise dans le document cadre de gouvernance du tableau de bord. Malgr&#xE9; cela, cette liste ne pr&#xE9;cise pas l&apos;affectation des r&#xF4;les et responsabilit&#xE9;s aux postes. Ainsi, &#xE0; travers l&apos;atelier de formation sur le tableau de bord, l&apos;&#xE9;quipe r&#xE9;gionale, district et formations sanitaires ont &#xE9;tabli une matrice RACI (Responsability, Accountability, Consulted, Informed) pr&#xE9;cisant les postes concern&#xE9;s par chaque attribution.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Finalize the interoperability process of DHIS2 with other software (CHANEL, SEIE, GESRESS, etc.);
Train managers of the various programs at central, regional and district level on the use of DHIS2;
Develop a validation guide. WHO HIV/Malaria/Cause of Deaths Dashboards</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Support Plan to MOH DHIS2 Implementation by HISP with GAVI Support ? Madagascar: DHIS2 Instances, Hosting and System Administration, Data Reporting and Integration in DHIS2, Infrastructure for DHIS2, Metadata Design in the current production instance configuration, User Management and Support, HR Capacity for DHIS2, Data and Information Use and Governance and Coordination">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Appui &#xE0; la mise en ?uvre du plan de transition du DVDMT vers DHIS2 &#xE0; travers le suivi de l&apos;effectivit&#xE9; des directives du Minist&#xE8;re sur l&apos;arr&#xEA;t de l&apos;utilisation de DVDMT &#xE0; partir de Janvier 2021
S&#xE9;ance de travail avec HISP et DEPSI pour la configuration de RIM Export, Immunization analysis et WHO data quality tools.
La digitalisation va prendre de plus en plus de l&apos;importance avec la vaccination contre la Covid-19, notamment avec l&apos;utilisation du GIS pour la micro-planification et le suivi, utilisation QR code,... Un appui cons&#xE9;quent est souhait&#xE9; dans ce domaine.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Support Plan to MOH DHIS2 Implementation by HISP with GAVI Support ? Madagascar: DHIS2 Instances, Hosting and System Administration, Data Reporting and Integration in DHIS2, Infrastructure for DHIS2, Metadata Design in the current production instance configuration, User Management and Support, HR Capacity for DHIS2, Data and Information Use and Governance and Coordination">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Appui &#xE0; la mise en ?uvre du plan de transition du DVDMT vers DHIS2 &#xE0; travers le suivi de l&apos;effectivit&#xE9; des directives du Minist&#xE8;re sur l&apos;arr&#xEA;t de l&apos;utilisation de DVDMT &#xE0; partir de Janvier 2021
S&#xE9;ance de travail avec HISP et DEPSI pour la configuration de RIM Export, Immunization analysis et WHO data quality tools.
La digitalisation va prendre de plus en plus de l&apos;importance avec la vaccination contre la Covid-19, notamment avec l&apos;utilisation du GIS pour la micro-planification et le suivi, utilisation QR code,... Un appui cons&#xE9;quent est souhait&#xE9; dans ce domaine.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 50% of districts have a Data Verification Factor (VAR, Penta 3) of at least 80% (source DQS)
 
 Difference (in percentage points) between the immunization coverage of Pentavalent 3 from
 administrative data as well as coverage vaccine from Pentavalent 3 from a survey immunization coverage</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Contribute to the promotion of the use of high quality data for better decision making.
Support the implementation of the data quality improvement plan at national level 
Support data analysis and monitoring of the country&apos;s EPI performance at national and regional levels and provide regular feedback 
Support the regional and districts in the application of self-assessment tools for data quality (DQS, ...), follow-up of the implementation of correction plans and in the use of new technologies to improve the quality of the data.
Support the implementation of the National Coverage Survey &quot;
Support the functionality of the DHIS2 in general and the use of the WHO applications on analysis and data quality">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Contribute to the promotion of the use of high quality data for better decision making.
Support the implementation of the data quality improvement plan at national level 
Support data analysis and monitoring of the country&apos;s EPI performance at national and regional levels and provide regular feedback 
Support the regional and districts in the application of self-assessment tools for data quality (DQS, ...), follow-up of the implementation of correction plans and in the use of new technologies to improve the quality of the data.
Support the implementation of the National Coverage Survey &quot;
Support the functionality of the DHIS2 in general and the use of the WHO applications on analysis and data quality">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Advocacy strategy to increase domestic political will and government funding for immunisation developed/implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la preparation/mise en oeuvre d&apos;une strategie de plaidoyer pour accroitre la volonte politique et le financement public de la vaccination">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Avec les staffs disponibles et en attendant le recrutement du consultant, un suivi r&#xE9;gulier est fait pour le paiement par l?Etat des obligations 2021 avec le Ministere de la Sante, des Finances et Supply Division. Un courrier de rappel a ete envoye en aout 2021 aux Ministeres des Finances et de la Sante avec un point sur la situation des stocks comme argumentaire de l&apos;urgence de proceder au paiement. A l&apos;heure actuelle, une lettre d&apos;autorisation d&apos;engagement d&apos;un montant de 3,5 millions USD a ete formulee par le Ministre de la Sante Publique, signee par le Premier Ministre et sounmise a la signature du President de la Republique.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of annual EPI performance review report  output by district is avaibable with key actions for improvement for all districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination, planning and implementation of the routine immunization revitalization strategies (RED approach/ACC Atteindre Chaque Cible, MCHW, AVW, Urban approach,...) , the monitoring and evaluation of the cMYP, the EPI annual plan,  supportive supervision, with special focus of supportive supervision in in the 33 priority districts.">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;approche atteindre chaque cible reste la strat&#xE9;gie utilis&#xE9;e dans le pays dans le cadre du PEV. A cet effet, le guide actualis&#xE9; selon le contexte de Madagascar a &#xE9;t&#xE9; reproduit et dispatch&#xE9; &#xE0; tous les niveaux du syst&#xE8;me de sant&#xE9; et aupr&#xE8;s de toutes les parties prenantes du PEV. 
Au niveau r&#xE9;gional, 10 Assistants Techniques R&#xE9;gionaux (Analamanga, Itasy, Bongolava, Betsiboka, Atsinanana, Alaotra Mangoro, Atsimo Atsinanana, Melaky, Anosy, Ihorombe) sont d&#xE9;ploy&#xE9;s afin d&apos;appuyer le niveau op&#xE9;rationnel dans la mise en oeuvre des activit&#xE9;s du PEV &#xE0; travers des supervisions formatives et dans l&apos;optique d&apos;un transfert de comp&#xE9;tence. Compte tenu de la pand&#xE9;mie de la covid-19 et notamment l&apos;arriv&#xE9;e de la seconde vague et les diff&#xE9;rentes mesures prises par le gouvernement dans le cadre de la riposte, les activit&#xE9;s ont &#xE9;t&#xE9; ax&#xE9;es sur l&apos;introduction du vaccin contre la covid-19. Des vaccinations de rattrapage sont pr&#xE9;vus pour atteindre les enfants z&#xE9;ro doses et les cibles ayant manqu&#xE9;s leurs doses</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination, planning and implementation of the routine immunization revitalization strategies (RED approach/ACC Atteindre Chaque Cible, MCHW, AVW, Urban approach,...) , the monitoring and evaluation of the cMYP, the EPI annual plan,  supportive supervision, with special focus of supportive supervision in in the 33 priority districts.">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;approche atteindre chaque cible reste la strat&#xE9;gie utilis&#xE9;e dans le pays dans le cadre du PEV. A cet effet, le guide actualis&#xE9; selon le contexte de Madagascar a &#xE9;t&#xE9; reproduit et dispatch&#xE9; &#xE0; tous les niveaux du syst&#xE8;me de sant&#xE9; et aupr&#xE8;s de toutes les parties prenantes du PEV. 
Au niveau r&#xE9;gional, 10 Assistants Techniques R&#xE9;gionaux (Analamanga, Itasy, Bongolava, Betsiboka, Atsinanana, Alaotra Mangoro, Atsimo Atsinanana, Melaky, Anosy, Ihorombe) sont d&#xE9;ploy&#xE9;s afin d&apos;appuyer le niveau op&#xE9;rationnel dans la mise en oeuvre des activit&#xE9;s du PEV &#xE0; travers des supervisions formatives et dans l&apos;optique d&apos;un transfert de comp&#xE9;tence. Compte tenu de la pand&#xE9;mie de la covid-19 et notamment l&apos;arriv&#xE9;e de la seconde vague et les diff&#xE9;rentes mesures prises par le gouvernement dans le cadre de la riposte, les activit&#xE9;s ont &#xE9;t&#xE9; ax&#xE9;es sur l&apos;introduction du vaccin contre la covid-19. Des vaccinations de rattrapage sont pr&#xE9;vus pour atteindre les enfants z&#xE9;ro doses et les cibles ayant manqu&#xE9;s leurs doses</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">cMYP revised, including the recommendations of the external review, available
# of areas  that have implemented vaccine survey as PWER WHO standards</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination of the external Comprehesnive EPI review, 
Support the implementation of the vaccination coverage survey as per the revised WHO standard 
Support the coordiantion and implementation of the GAVI JA (Full portifolio planning preparation for 2021)">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">La r&#xE9;vision du PPAC est pr&#xE9;vue en septembre 2021. Le processus de la revue externe va comment en juillet 2021. Les consultants internationaux qui doivent coordonner le processus sont d&#xE9;j&#xE0; identifi&#xE9;s et le recrutement est en cours.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination of the external Comprehesnive EPI review, 
Support the implementation of the vaccination coverage survey as per the revised WHO standard 
Support the coordiantion and implementation of the GAVI JA (Full portifolio planning preparation for 2021)">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">La r&#xE9;vision du PPAC est pr&#xE9;vue en septembre 2021. Le processus de la revue externe va comment en juillet 2021. Les consultants internationaux qui doivent coordonner le processus sont d&#xE9;j&#xE0; identifi&#xE9;s et le recrutement est en cours.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Policy &amp; Regulatory Environment</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NITAG recommendation on the prioritised new vaccines introduction submitted to EPI 
Collated evidence and information for NITAG delibrations available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the establishment and fonctionality of NITAG to facilitate decision making for vaccine introduction or reorientation of the program and the and the ICC revitalization.">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le NIATG sera cr&#xE9;e au sein de l&apos;Acad&#xE9;mie Nationale de M&#xE9;decine de Madagascar (ANAMEM). Les quinze membres ont &#xE9;t&#xE9; s&#xE9;lectionn&#xE9;s par l&apos;ANAMEM et en attente de nomination par un arr&#xEA;t&#xE9; Minist&#xE9;riel. Des r&#xE9;unions d&apos;orientation des membres sont pr&#xE9;vues avec des r&#xE9;unions p&#xE9;riodiques et/ou des r&#xE9;unions ponctuelles selon le contexte. Le Point Focal NITAG de AFRO a d&#xE9;j&#xE0; pr&#xE9;par&#xE9; l&apos;agenda pour la formation des membres du GTCV ainsi que le secr&#xE9;tariat, pour un fonctionnement optimal.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the establishment and fonctionality of NITAG to facilitate decision making for vaccine introduction or reorientation of the program and the and the ICC revitalization.">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le NIATG sera cr&#xE9;e au sein de l&apos;Acad&#xE9;mie Nationale de M&#xE9;decine de Madagascar (ANAMEM). Les quinze membres ont &#xE9;t&#xE9; s&#xE9;lectionn&#xE9;s par l&apos;ANAMEM et en attente de nomination par un arr&#xEA;t&#xE9; Minist&#xE9;riel. Des r&#xE9;unions d&apos;orientation des membres sont pr&#xE9;vues avec des r&#xE9;unions p&#xE9;riodiques et/ou des r&#xE9;unions ponctuelles selon le contexte. Le Point Focal NITAG de AFRO a d&#xE9;j&#xE0; pr&#xE9;par&#xE9; l&apos;agenda pour la formation des membres du GTCV ainsi que le secr&#xE9;tariat, pour un fonctionnement optimal.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Existence of a routine immunization strengthening plan integrated with other interventions that will be coordinated through the 2YL vaccination platform</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="The Vaccination 2YL Immunization Platform is set up : Support the establishment of the platform for vaccination in the second year of life to support the introduction of MCV 2 and other vaccines">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le lancement officiel de l?introduction du VAR 2 &#xE0; Madagascar s?est r&#xE9;alis&#xE9;e le 30 septembre 2020 avec un niveau des pr&#xE9;paratifs du dashboard sup&#xE9;rieur &#xE0; 80%. Les 114 districts ont tous introduit le vaccin. Le comit&#xE9; de coordination ainsi que les 5 sous-comit&#xE9;s ont &#xE9;t&#xE9; &#xE9;rig&#xE9; le 7 septembre 2020. La r&#xE9;union de mise en place du comit&#xE9; de pilotage avec nomination des membres s?est tenue le 1er octobre 2020. Des activit&#xE9;s de supervisions ont &#xE9;t&#xE9; men&#xE9;es dans 401 CSB, 85 districts et 22 r&#xE9;gions par les 44 superviseurs du Minist&#xE8;re de la sant&#xE9; publique et 9 de l?OMS. La r&#xE9;union de d&#xE9;briefing des superviseurs a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e le 9 mars 2021.
L?&#xE9;valuation post introduction du VAR2 pr&#xE9;vue pour le 2&#xE8; trimestre 2021 est report&#xE9;e en octobre compte tenu de l?urgence covid 19.
Le briefing de l&apos;ancien SG a &#xE9;t&#xE9; r&#xE9;alis&#xE9; le 18 aout 2020.
Le nouveau SG doit encore fixer la date pour son briefing et par la suite son approbation afin de mettre en place de la plateforme 2YL.
Face &#xE0; la situation sanitaire actuelle, toutes les entit&#xE9;s du Minist&#xE8;re de la sant&#xE9; publique se sont mobilis&#xE9;es sur les activit&#xE9;s de lutte contre la covid 19. L&apos;orientation du nouveau SG concernant la plateforme et sa mise en place ont &#xE9;t&#xE9; report&#xE9; mais le Groupe Technique de Travail sur le D&#xE9;ploiement des vaccins Covid-19 (qui int&#xE9;gr&#xE9; diff&#xE9;rents direction, minist&#xE8;res, secteurs et les partenaires) servira de plateforme pour la vaccination tout au long de la vie.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="The Vaccination 2YL Immunization Platform is set up : Support the establishment of the platform for vaccination in the second year of life to support the introduction of MCV 2 and other vaccines">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le lancement officiel de l?introduction du VAR 2 &#xE0; Madagascar s?est r&#xE9;alis&#xE9;e le 30 septembre 2020 avec un niveau des pr&#xE9;paratifs du dashboard sup&#xE9;rieur &#xE0; 80%. Les 114 districts ont tous introduit le vaccin. Le comit&#xE9; de coordination ainsi que les 5 sous-comit&#xE9;s ont &#xE9;t&#xE9; &#xE9;rig&#xE9; le 7 septembre 2020. La r&#xE9;union de mise en place du comit&#xE9; de pilotage avec nomination des membres s?est tenue le 1er octobre 2020. Des activit&#xE9;s de supervisions ont &#xE9;t&#xE9; men&#xE9;es dans 401 CSB, 85 districts et 22 r&#xE9;gions par les 44 superviseurs du Minist&#xE8;re de la sant&#xE9; publique et 9 de l?OMS. La r&#xE9;union de d&#xE9;briefing des superviseurs a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e le 9 mars 2021.
L?&#xE9;valuation post introduction du VAR2 pr&#xE9;vue pour le 2&#xE8; trimestre 2021 est report&#xE9;e en octobre compte tenu de l?urgence covid 19.
Le briefing de l&apos;ancien SG a &#xE9;t&#xE9; r&#xE9;alis&#xE9; le 18 aout 2020.
Le nouveau SG doit encore fixer la date pour son briefing et par la suite son approbation afin de mettre en place de la plateforme 2YL.
Face &#xE0; la situation sanitaire actuelle, toutes les entit&#xE9;s du Minist&#xE8;re de la sant&#xE9; publique se sont mobilis&#xE9;es sur les activit&#xE9;s de lutte contre la covid 19. L&apos;orientation du nouveau SG concernant la plateforme et sa mise en place ont &#xE9;t&#xE9; report&#xE9; mais le Groupe Technique de Travail sur le D&#xE9;ploiement des vaccins Covid-19 (qui int&#xE9;gr&#xE9; diff&#xE9;rents direction, minist&#xE8;res, secteurs et les partenaires) servira de plateforme pour la vaccination tout au long de la vie.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Final report available and publication of 2 articles
 Number of surviving infants who received
 the last (second or third) dose
 recommended rotavirus vaccine</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the strengthening of surveillance of new vaccines (MBP, Hib and rotavirus) at the CHUMET sentinel site: rotavirus vaccine and PCV impact monitoring and the implementation of surveillance for congenital rubella syndrome Dissemination workshop on impact of new vaccines in Madgascar">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le site sentinelle au niveau du CHUMET poursuit la surveillance des nouveaux vaccins. La base de donn&#xE9;es est transmises mensuellement &#xE0; AFRO.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the strengthening of surveillance of new vaccines (MBP, Hib and rotavirus) at the CHUMET sentinel site: rotavirus vaccine and PCV impact monitoring and the implementation of surveillance for congenital rubella syndrome Dissemination workshop on impact of new vaccines in Madgascar">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le site sentinelle au niveau du CHUMET poursuit la surveillance des nouveaux vaccins. La base de donn&#xE9;es est transmises mensuellement &#xE0; AFRO.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">cMYP revised, including the recommendations of the external review, available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the external EPI review and the vaccination coverage survey">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le processus FPP est en cours avec l&apos;Enqu&#xEA;te de Couverture Vaccinale qui va bient&#xF4;t &#xEA;tre finalis&#xE9;e. La pr&#xE9;paration de la revue externe est en cours et aboutira &#xE0; la r&#xE9;vision du PPAc sous le nouveau format de Strat&#xE9;gie Nationale de la Vaccination.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete end-of-ISDS transition activity review to report on the sustainability of ISDS activities in the5 implementation regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Completion of STOP Immunisation and Surveillance Data Specialist (ISDS) pilot and transition to ensure sustainable improvements in immunization and VPD surveillance data management, quality and use through sustained supportive supervision">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Minor delays - ISDS transition activities have been unerway since Q2 of 2021 and if there are no further major delays due to COVID, it should be possible to review all transition activities and report out on their progress in Q2 of 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Completion of STOP Immunisation and Surveillance Data Specialist (ISDS) pilot and transition to ensure sustainable improvements in immunization and VPD surveillance data management, quality and use through sustained supportive supervision">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Minor delays - ISDS transition activities have been unerway since Q2 of 2021 and if there are no further major delays due to COVID, it should be possible to review all transition activities and report out on their progress in Q2 of 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Completion of STOP Immunisation and Surveillance Data Specialist (ISDS) pilot and transition to ensure sustainable improvements in immunization and VPD surveillance data management, quality and use through sustained supportive supervision">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">On track with minor delays.The ISDS transition in Madagascar began earlier this year but has encountered a few delays in getting activities started at a routine pace. The transition activities will continue to take place through the middle of next year before the sustainable transition back to the MOH. Monitoring of transition activities is ongoing and hope for a field visit next year to observe transition activities, support presentation of monitoring results, and help finalize monitoring dashboard.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete routine supportive supervision of ongoing STOP ISDS transisition activities and continue summative assessment of STOP ISDS pilot implementation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Completion of STOP Immunisation and Surveillance Data Specialist (ISDS) pilot and transition to ensure sustainable improvements in immunization and VPD surveillance data management, quality and use through sustained supportive supervision">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Minor delays - in-country supportive supervision completed by the STOP ISDS transition coordinator will be possible in 2021 in a limited scope based on the COVID travel procedures in country. Remote supportive supervision has been provided by the transiition coordinator since late 2020. Continuation of summative assessment of STOP ISDS pilot implementation is on hold until international CDC travekl resumes.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN"># Progress report with main lessons learned available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="# Support the development of REC effective implementation and monitoring of progress in urban priority districts to improve immunization coverage among the urban poor and marginalized/ excluded; # Adapt stratey / tools for micro planning and implementation strategies based on Tana ville lessons learned # Support scale up in selected districts">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Program Area: Program implementation/ Coverage and equity
# J?ai contribu&#xE9; &#xE0; l?amendement jusqu?en D&#xE9;cembre 2021 du contrat du consultant international charg&#xE9; de la mise &#xE0; l?&#xE9;chelle de l?approche urbaine, qui en raison du contexte de la pand&#xE9;mie de COVID 19, devra fournir plus de travail &#xE0; distance et son contrat a &#xE9;t&#xE9; amend&#xE9;. Ainsi l?appui pour le renforcement de capacit&#xE9;s des principaux acteurs au niveau District et R&#xE9;gion de m&#xEA;me l?appui &#xE0; la planification et la documentation se feront &#xE0; distance &#xE0; travers des sessions virtuelles. Avec le consultant international, la documentation de l?approche urbaine a &#xE9;t&#xE9; consolid&#xE9;e et partagee a un webinar r&#xE9;gional UNICEF OMS sur l?Immunization en milieu urbain. Les le&#xE7;ons clefs dans les 4 villes sont : 
?	La couverture vaccinale des donn&#xE9;es du DVD MT peuvent induire en erreur en ville pour identifier Z&#xE9;ros doses par CSB ou FKT 
?	Un focus doit &#xEA;tre mis sur les CSB et FKT avec le plus de z&#xE9;ros doses et perdus de vue
?	Les Strat&#xE9;gies avanc&#xE9;es am&#xE9;lior&#xE9;es (ajout d&apos;une ou plusieurs intervention) sont n&#xE9;cessaires en ville pour r&#xE9;duire le nombre de z&#xE9;ros doses et perdus de vue (toutes les m&#xE8;res &#xE0; moins de 2km d?un site de vaccination)
?	L?Engagement des AC et chef FKT et AS est clef (comp&#xE9;tence, motivation, redevabilit&#xE9; de leurs T&#xE2;ches et objectifs &#xE0; atteindre sont essentiels) et les AC identifier les femmes enceinte et enfants de leurs secteurs pour &quot;lister enregistrer et suivre&quot; l&apos;&#xE9;tat vaccinal des cibles avec une formation et suivi de qualit&#xE9;, ex&#xE9;cuter les t&#xE2;ches respectives 
?	Le Monitorage et suivi p&#xE9;riodique de qualit&#xE9; d&apos;ex&#xE9;cution des actions et performance fera la diff&#xE9;rence avec FOCUS sur CSB et FKT prioritaire
La mise a disposition des fonds est en cours pour la mise en ?uvre des microplans des centres de sant&#xE9; prenant en compte &#xAB; l?aspect urbain &#xBB;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN"># Reports generated from the training
# Follow - up and feedback  provided  to districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capacity building of EPI managers at all levels: 
MLM training new design in 114 Districts , 
training of health workers (vaccination in practice and monitoring of VPDs and AEFIs) in 2600 HFs in 114 Districts in 22 regions.
Conduct regular performance Monitoring and evaluation, particularly in 33 prioritiy districts using score cards and provide monthly feedback, 
Conduct  at least 4 suportive supervision visits to priority 33 districts and provide onsite feedback for improvement 
Coordinate at lest 2 periodic performance reviews of distsricts at regional level for  improved data quality, etc.)">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Suite &#xE0; la formation MLM des gestionnaires du PEV en f&#xE9;vrier 2020 (staff de la DPEV, les responsables PEV r&#xE9;gionaux, PTF), une formation en PEV pratique est pr&#xE9;vue au quatri&#xE8;me trimestre de cette ann&#xE9;e pour le niveau op&#xE9;rationnel. La r&#xE9;vision du curriculum de formation est en cours.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support capacity building of EPI managers at all levels: 
MLM training new design in 114 Districts , 
training of health workers (vaccination in practice and monitoring of VPDs and AEFIs) in 2600 HFs in 114 Districts in 22 regions.
Conduct regular performance Monitoring and evaluation, particularly in 33 prioritiy districts using score cards and provide monthly feedback, 
Conduct  at least 4 suportive supervision visits to priority 33 districts and provide onsite feedback for improvement 
Coordinate at lest 2 periodic performance reviews of distsricts at regional level for  improved data quality, etc.)">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Suite &#xE0; la formation MLM des gestionnaires du PEV en f&#xE9;vrier 2020 (staff de la DPEV, les responsables PEV r&#xE9;gionaux, PTF), une formation en PEV pratique est pr&#xE9;vue au quatri&#xE8;me trimestre de cette ann&#xE9;e pour le niveau op&#xE9;rationnel. La r&#xE9;vision du curriculum de formation est en cours.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">An annual/rolling operational plan for immunisation developed by MOH/EPI (country-led, with capacity building component)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination, planning and implementation of the routine immunization revitalization strategies (RED approach/ACC Atteindre Chaque Cible, MCHW, AVW, Urban approach,...) , the monitoring and evaluation of the cMYP, the EPI annual plan, supportive supervision, with support for the National Immunization Strategic plan development aligned with leave no one behindthe and the entire GAVI Full Portfolio Planning process, Support the coordination of the external Comprehesnive EPI review;">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le Plan de Travail Annuel a &#xE9;t&#xE9; &#xE9;labor&#xE9; depuis le d&#xE9;but de l&apos;ann&#xE9;e 2021, avec implication de toutes les parties prenantes. Ce plan s&apos;est bas&#xE9; sur le recommandations du Dialogue Multi Partite r&#xE9;alis&#xE9;e en d&#xE9;cembre 2020</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Medium-term costed strategic plan for immunisation (National Immunisation Strategy) developed by MOH/EPI and integrated with national health strategy (country-led, with a capacity building component)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination, planning and implementation of the routine immunization revitalization strategies (RED approach/ACC Atteindre Chaque Cible, MCHW, AVW, Urban approach,...) , the monitoring and evaluation of the cMYP, the EPI annual plan, supportive supervision, with support for the National Immunization Strategic plan development aligned with leave no one behindthe and the entire GAVI Full Portfolio Planning process, Support the coordination of the external Comprehesnive EPI review;">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">The EPI Direction has been supported in the development of EPI standards and procedures, the document is being finalized. The practical EPI training curriculum development workshop was held on October 14, 2021 and will be followed by the finalization and validation workshop. The external review of the EPI started in August 2021 using the new WHO guideline. An international and a national consultant were hired and supported the country, then the documentary review workshop was carried out from August 6 to 10 with the participation of all EPI stakeholders. This review highlighted the strengths and weaknesses of the EPI system according to the 7 thematic groups: program management and finance, human resources, logistics and supply, service service, vaccination coverage, VPD and AEFI surveillance, demand generation. External review survey has taken in place from 25 to 30 October and concerned the 22 regions, 44 districts and 88 health facilities. 
The workshop for data analysis was held from October 18-22 with the participation of thematic group leaders, central supervisors and technical and financial partners. The report is being finalized and will be validated with the technical CCIA. The recommendations will be presented to the decision-making ICC to be integrated in the strategic planning.
The report is being finalized. The external review, which also followed the process well, is in the process of finalizing its final report. 
It should also be noted that the EVM evaluation was carried out in this process as well as the development of the improvement plan.
The cMYP or National Immunization Strategy will be developed in December 2021, before continuing with the GAVI FPP process.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Routine immunisation coverage survey (national /targeted - various methods) implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Contribute to the promotion of the use of high quality data for better decision making.
Support the implementation of the data quality improvement plan at national level 
Support data analysis and monitoring of the country&apos;s EPI performance at national and regional levels and provide regular feedback 
Support the regional and districts in the application of self-assessment tools for data quality (DQS, ...), follow-up of the implementation of correction plans and in the use of new technologies to improve the quality of the data.
Support the implementation of the National Coverage Survey &quot;
Support the functionality of the DHIS2 in general and the use of the WHO applications on analysis and data quality">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">The monitoring of the implementation of the data improvement plan is carried out quarterly, activities related to the transition from DVDMT to DHIS2 have been prioritized such as the finalization of the configuration of the WHO additive packages as well as the export of the RIM database from DHIS2. The support of the MoH was made in the coordination of multiple interventions from stakeholders and HISP. The analysis of routine immunization data is carried out monthly on the basis of data from DHIS2, feedback on the quality of the data and the immunization performance are shared with a follow-up of the completeness and quality of the data (outliers and missing values) . The DQS are carried out by the district level with the support of the WHO consultants int he region, the data collection is done with ODK platform and the reports are sent to the central level to be summarized with the recommendations. The immunization coverage survey has been carried out with two workshop on July to elaborate the report and to present the result, the final report is on track. For AVS, the data collection system was reviewed using the ODK plateform and dashboard on powerbi was shared, thus facilitate the monitoring at all levels as well as the availability and the quality of the data to provide the daily bulletin of the two rounds of the campaign. The second round of the COVID19 vaccination was supported by the management tools revision (paper and electronic), the review of data flow map to reduce the waste of time in the registration. The training module and the guidelines for using electronic tools (DHIS2 tracker) have been developed and shared. MoH is supported in the preparation of GTTN and QGO meetings to present updated data as well as in the data regularization through the data management committee. As perspectives, training of trainers in the use of routine data and covid19 vaccination on DHIS2 is planned and will be followed by the training at region and district level.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery approach suitable to reach missed communities &amp; defualtd from immunizaiton identified and endorsed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support all districts in developing or updating their EPI annual operational work plan that is informed by the equity analysis with strategies of Reach Every Community appraoch to guide standard operations (including addressing of MOV; prioritize Zero dose, undervaccinated, marginalized populations and urban Immunization ) using the different Immunization assesment results (eg MOV, Urban immunization assesment, coverage survey etc...)">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">The regional technical assistant support the implementation of EPI activities in 10 regions according to the approach to achieve each target and actively participate in coordination meetings at the regional level. Skills transfers are carried out during the integrative support supervision carried out jointly with the EMAR (regional management team) and EMAD (district management team). They supported also the planning and the implementation of the two rounds of the reactive polio vaccination campaign (June and August 2021) and performed the independent monitoring and LQAS surveys.
They also support the COVID19 vaccination through the training, supportive supervision at vaccination sites, notification of AEFI cases and data reporting.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="# Appui au renforcement de la vaccination de routine y compris le rattrapage des zero-doses/enfants des communautes negligees, la mise en oeuvre de l&apos;ACC dans les 8 grandes villes et l&apos;introduction du VPI2 Activites: (i) Appuyer l&apos;elaboration du plan de rattrapage des enfants &#xAB; z&#xE9;ro dose &#xBB; ainsi que ceux des communaut&#xE9;s n&#xE9;glig&#xE9;es; (ii) Soutenir la mise en oeuvre de l&apos;approche urbaine dans 5 Villes (Tana, Fianarantsoa I, Majunga I, Antsirabe I, Tulear I) et l&apos;extension dans 3 autres Villes (Toamasina I, Diego I, Ambositra I); (iii) Soutenir les preparatifs et la mise en oeuvre de qualite de la campagne de suivi rougeole integree a la supplementation en Vitamine A; (iv) Appuyer la revision des outils de microplanification et la tenue des ateliers de microplanification dans les districts prioritaires identifies par l&apos;analyse de l&apos;equite; (v) Soutenir la mise en oeuvre des microplans des districts prioritaires; (vi) Documenter la mise en oeuvre des microplans">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">i Plan rattrapage zero doses disponible: appui a l&apos;analyse des donnees pour identifier les districts qui concentrent le maximun de zero doses, microplanification en cours pour demarrer le rattrapage des disponibilite vaccins. Le pays connait ruptures pour retard paiement cofinancement
ii Avec le consultant international, appui a l?orientation des equipes de districts,formation agents des sante et agents communautaires sur l&apos;approche urbaine pour elaboration de microplans incluant des strategies avancees ameliorees. Resultats: 492 enfants supplementaires vaccines au DTCHepBHib 1 et 599 enfants au DTCHepBHib3 en Juillet et Aout 2021 compares a juilet aout 2020 grace aux strategies avancees ameliorees. N&#xE9;anmoins la couverture cumulee au DTCHepBHib 3 en Septembre 2021 varie de 79 &#xE0; 89%; inf&#xE9;rieure &#xE0; celle de Septembre ( 89 &#xE0; 99%). Une meilleure disponibilite des vaccins aurait permis un impact significatif sur les couvertures vaccinales.Pour l&apos;approche urbaine, extension dans 2 villes Toamasina I, Diego I avec des preparatifs pour un demarrage en decembre
iii Introduction VPI2: appui aux preparatifs; &#xE9;laboration guide d&apos;introduction,supports de formation, outils de collecte de donn&#xE9;es (reprographie en cours).
v Campagne rougeole reportee en mars 2022. Appui a l&apos;elaboration du chronogramme detaille, canevas microplanification
Preparation FPP: participation a l?analyse de la couverture et &#xE9;quit&#xE9; avec l&apos;appui d&apos;un consultant international. Resultats: identification districts prioritaires (22), formation equipe centrale/EMAR/EMAD de 4 r&#xE9;gions (Analamanga, Vakinakaratra, Menabe, Amoron?i Mania) et 4 districts( TanaVille, Antsirabe2, Mahabo,Ambatofinandrahana). Tana ville, Antsirabe2 ont ete forme et disposent de microplans bases sur l&apos;equite.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete end-of-phase 4 review meeting to report on results from the two years of the STOP ISDS pilot implementation in 5 provinces</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Completion of STOP Immunisation and Surveillance Data Specialist (ISDS) pilot and transition to ensure sustainable improvements in immunization and VPD surveillance data management, quality and use through sustained supportive supervision">
      <location ref="MG"></location>
     </target>
     <actual value="Completed">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Completed - virtual end-of-phase 4 review meeting was conducted with all in-country partners and Atlanta-based CDC staff last July. Follow-up meetings to this virtual review meeting were conducted by the STOP ISDS in-country coordinator.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete end-of-phase 4 review meeting to report on results from the second year of STOP ISDS pilot implementation in 5 regions; Complete first round of summative assessment of pilot implementation in Madagascar</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="STOP Immunisation and Surveillance Data Specialist (ISDS) pilot to improve immunization and VPD surveillance data management, quality and use">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="MG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. VPD surveillance digital package installed
2. AFRO country: Reporting to AFRO regional DHIS2 established</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on VPD surveillance digital data package and know how to use it.
Costed scale up plan exist.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of VPD surveillance">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Dalberg Global Development Advisors : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A framework will be co-created with the EPI team at the central level to monitor the respect of the standard operating procedures. The relevant EPI personnel will be empowered and coached to start the monitoring and enforcement of EPI SOPs at the subnational level.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Des s&#xE9;ances de travail avec l&apos;&#xE9;quipe de la DPEV et celle de la DGMP ont &#xE9;t&#xE9; men&#xE9;es au mois de juillet. Compte tenu de leurs disponibilit&#xE9;s, la pr&#xE9;sentation du document aupr&#xE8;s des staffs de la DPEV ne sera possible que vers le d&#xE9;but de l&apos;ann&#xE9;e 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The MP will provide a status update and course correction measures for H1, H2 and H3 objectives, as per the institutional development plan. He/She will drive the EPI management and team towards achieving H4 milestones.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementing the recommendations suggested in the report: &quot;Evaluation du PEV Madagascar (GAVI/Dalberg)&quot;, beyond the aforementioned tasks.">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le nouvel organigramme de la DPEV est en cours de r&#xE9;vision avec le nouveau Directeur. La mise en place du dashboard fait l&apos;objet d&apos;un projet &#xE0; part. Les membres du GTCV ont &#xE9;t&#xE9; d&#xE9;sign&#xE9;s et son Pr&#xE9;sident est connu. Les r&#xE9;unions du CCIA font l&apos;objet de PV. Les r&#xE9;unions du staff de la DPEV et des services sont tenues.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementing the recommendations suggested in the report: &quot;Evaluation du PEV Madagascar (GAVI/Dalberg)&quot;, beyond the aforementioned tasks.">
      <location ref="MG"></location>
     </target>
     <actual value="On Track">
      <location ref="MG"></location>
      <comment>
       <narrative xml:lang="EN">Le nouvel organigramme de la DPEV est en cours de r&#xE9;vision avec le nouveau Directeur. La mise en place du dashboard fait l&apos;objet d&apos;un projet &#xE0; part. Les membres du GTCV ont &#xE9;t&#xE9; d&#xE9;sign&#xE9;s et son Pr&#xE9;sident est connu. Les r&#xE9;unions du CCIA font l&apos;objet de PV. Les r&#xE9;unions du staff de la DPEV et des services sont tenues.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Marked improvement in team effectiveness and efficiency is demonstrated through assessment of metrics defined during the initial assessment. Ongoing training coaching and mentoring of EPI personnel.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop modern human resources management and instill a results and performance-driven culture aligned with the Ministry of Health (MoH) HR regulations and with best practices on performance incentives.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop modern human resources management and instill a results and performance-driven culture aligned with the Ministry of Health (MoH) HR regulations and with best practices on performance incentives.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Marked improvement in team effectiveness and efficiency is demonstrated through assessment of metrics defined during the initial assessment. Ongoing training, coaching and mentoring of EPI personnel at the subnational level.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop modern human resources management practices and instill a results and performance-driven culture aligned with the central level and with best practices on performance incentives.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop modern human resources management practices and instill a results and performance-driven culture aligned with the central level and with best practices on performance incentives.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">These champions will have demonstrated a strong impact on the EPI which will be reflected in the delivery of the immunization program and the overall engagement of the EPI team and associated partners.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identify champions amongst the extended immunisation teams to groom them for peer-leadership and ensure overall strengthening of the EPI.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Identify champions amongst the extended immunisation teams to groom them for peer-leadership and ensure overall strengthening of the EPI.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The capacity building plan in all selected departments is implemented through training sessions and/or coaching. The M&amp;E framework of department-level activities is fully operational, and reports are produced quarterly on department operations performance.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen coordination and communication between the EPI at the central level and program managers in the DDS (Sanitation Departments), with particular attention to the less efficient DDS.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen coordination and communication between the EPI at the central level and program managers in the DDS (Sanitation Departments), with particular attention to the less efficient DDS.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The EPI team is fully able to independently track, monitor, provide timely corrective actions, evaluate and report on programme delivery. The EPI leadership is able to present and leverage program delivery results to lobby for fundraising. 
Data-backed analyses stemming from EPI dashboards will be used routinely in MOH meetings to create a culture of advocacy and resource mobilization based on data.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen the capacity of the EPI?s leadership in program management, and provide them with the appropriate management approaches, techniques and tools.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen the capacity of the EPI?s leadership in program management, and provide them with the appropriate management approaches, techniques and tools.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The selected district teams are fully able to independently track, monitor, provide timely corrective actions, evaluate and report on programme delivery. The subnational level leadership is able to present and leverage program delivery results to lobby at the central level for fundraising. 
Data-backed analyses stemming from EPI dashboards will be used routinely in regional meetings to create a culture of advocacy and resource mobilization based on data.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen the capacity of the selected districts in program management, planning, provide them with the appropriate management approaches, techniques and tools.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen the capacity of the selected districts in program management, planning, provide them with the appropriate management approaches, techniques and tools.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The MP will support the EPI Director in managing her relations with the main partners of the EPI, on an ad hoc basis.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination forum through adequate organisatonal, and reporting tools.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination forum through adequate organisatonal, and reporting tools.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The MP will support the management team at the regional level to make informed decisions based on the relevant data collected and share key findings with the central level.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination forum through adequate reporting tools and relevant data.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination forum through adequate reporting tools and relevant data.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Based on the initial evaluation of the new SOPs, adjustments will be proposed if needed. A continuous improvement framework will be designed and shared with the EPI management and relevant personnel.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the organizational improvement of the EPI at the subnational level by implementing procedures developed by the MP at the central level. The manual of procedures will codify strategic objectives and program management procedures and will play a pivotal role in ensuring the efficiency and effectiveness of the teams.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the organizational improvement of the EPI at the subnational level by implementing procedures developed by the MP at the central level. The manual of procedures will codify strategic objectives and program management procedures and will play a pivotal role in ensuring the efficiency and effectiveness of the teams.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the organizational improvement of the EPI by developing a manual of procedures. The manual of procedures will codify strategic objectives and program management procedures and will play a pivotal role in ensuring the efficiency and effectiveness of the teams.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the organizational improvement of the EPI by developing a manual of procedures. The manual of procedures will codify strategic objectives and program management procedures and will play a pivotal role in ensuring the efficiency and effectiveness of the teams.">
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A framework will be co-created with the EPI team to monitor the respect of the standard operating procedures. The relevant EPI personnel will be empowered and coached to start the monitoring and enforcement of EPI SOPs. A survey will be developed to assess whether the new procedures meet their intended purpose in inducing higher EPI performance and greater ease of collaboration (internal and external survey).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The MP will develop a training plan for the staff in charge of monitoring and evaluation and surveillance at the operational level and will establish a results-oriented culture within the EPI (central and operational levels) that takes into account collective and individual performance.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The MP will develop a training plan for the staff in charge of monitoring and evaluation and surveillance at the subnational level and establish a results-oriented culture that takes into account collective and individual performance.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The MP will ensure implementation of the capacity building plan for the selected regions. An M&amp;E framework will be designed to monitor the performance of department-level operations fully.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The MP will provide a status update and course correction measures for H1 and H2 objectives, as per the institutional development plan. He/She will drive the EPI management and team towards achieving H3 milestones.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The MP will provide ad-hoc support for documentation required for new coordination mechanisms and follow up activities. The MP will conduct a satisfaction survey of the reliability of data collected at the subational level and make proposals to introduce improvements or corrective measures.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The MP will provide ad-hoc support on the documentation for the forum coordination and follow-up activities. The MP will conduct a satisfaction survey of the EPI activities among its main FTPs and propose improvements or corrective measures.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The leadership of the EPI management team at he subnational level will be assessed by the MP based on the EPI performance improvement in the selected districts, and identify managerial expertise gaps that will serve as themes for ongoing training and coaching sessions.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The leadership of the EPI will be assessed by the MP based on the EPI&apos;s performance improvement plan, and identify managerial expertise gaps (at individual and institutional levels) that will serve as themes for ongoing training and coaching sessions.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">These staff members will be given tailor-made coaching by professionals to support them in reaching their full leadership potential.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="MG"></location>
     </target>
     <actual>
      <location ref="MG"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
